2024
Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events (Journal article)
Buckley, B. J. R., Harrison, S. L., Lane, D. A., Hill, A., & Lip, G. Y. H. (2023). Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad211DOI: 10.1093/eurjpc/zwad211
Williams, N. H., Collins, B., Comerford, T. J., Dodd, S., Fisher, M., Hardwick, B., . . . Singh, S. J. (2024). Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart' Therapeutic E-intervention) randomised controlled trial.. BMJ open, 14(3), e084509. doi:10.1136/bmjopen-2024-084509DOI: 10.1136/bmjopen-2024-084509
Wafa, H. A., Marshall, I., Wolfe, C. D. A., Xie, W., Johnson, C. O., Veltkamp, R., . . . PRESTIGE-AF consortium. (2024). Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050.. The Lancet regional health. Europe, 38, 100842. doi:10.1016/j.lanepe.2024.100842DOI: 10.1016/j.lanepe.2024.100842
Sagris, D., Ntaios, G., Buckley, B. J. R., Harrison, S. L., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2024). Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation.. European journal of internal medicine, 121, 114-120. doi:10.1016/j.ejim.2023.10.033DOI: 10.1016/j.ejim.2023.10.033
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2024). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.. American heart journal, S0002-8703(24)00038-3. doi:10.1016/j.ahj.2024.02.011DOI: 10.1016/j.ahj.2024.02.011
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2024). Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18.. Age and ageing, 53(2), afae021. doi:10.1093/ageing/afae021DOI: 10.1093/ageing/afae021
Shantsila, E., Choi, E. -K., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024). Atrial fibrillation: comorbidities, lifestyle, and patient factors.. The Lancet regional health. Europe, 37, 100784. doi:10.1016/j.lanepe.2023.100784DOI: 10.1016/j.lanepe.2023.100784
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2024). Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study.. BMC geriatrics, 24(1), 64. doi:10.1186/s12877-023-04527-4DOI: 10.1186/s12877-023-04527-4
2023
Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2024). Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.. PloS one, 19(1), e0296413. doi:10.1371/journal.pone.0296413DOI: 10.1371/journal.pone.0296413
Verma, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2023). Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches.. Expert review of cardiovascular therapy, 21(12), 963-983. doi:10.1080/14779072.2023.2276892DOI: 10.1080/14779072.2023.2276892
Dementia risk among patients with atrial fibrillation treated with non-vitamin K vs. vitamin-K oral anticoagulants (Journal article)
Sagris, D., Ntaios, G., Harrison, S., Buckley, B., Underhill, P., Lane, D., & Lip, G. Y. H. (2023). Dementia risk among patients with atrial fibrillation treated with non-vitamin K vs. vitamin-K oral anticoagulants. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.484DOI: 10.1093/eurheartj/ehad655.484
Harrison, S. L., Buckley, B. J. R., Austin, P., Lane, D. A., & Lip, G. Y. H. (2023). Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.18538DOI: 10.1111/jgs.18538
Leo, D. G., Lane, D. A., Riley, M., Lotto, A. A., & Lotto, R. R. (2022). Facilitators and barriers of physical activity participation in children with a single ventricle physiology: a mixed-methods study. CARDIOLOGY IN THE YOUNG. doi:10.1017/S1047951122003754DOI: 10.1017/S1047951122003754
Psychological interventions for depression in adolescent and adult congenital heart disease. (Journal article)
Leo, D. G., Islam, U., Lotto, R. R., Lotto, A., & Lane, D. A. (2023). Psychological interventions for depression in adolescent and adult congenital heart disease.. The Cochrane database of systematic reviews, 10, CD004372. doi:10.1002/14651858.cd004372.pub3DOI: 10.1002/14651858.cd004372.pub3
Goulart, A. C., Varella, A. C., Gooden, T. E., Lip, G. Y. H., Jolly, K., Thomas, G. N., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2023). Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.. PloS one, 18(10), e0292463. doi:10.1371/journal.pone.0292463DOI: 10.1371/journal.pone.0292463
Creber, A., Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., . . . TAILOR investigators. (2023). Use of telemonitoring in patient self-management of chronic disease: a qualitative meta-synthesis.. BMC cardiovascular disorders, 23(1), 469. doi:10.1186/s12872-023-03486-3DOI: 10.1186/s12872-023-03486-3
Obaid Hassan, A., Moreno Lopez, R., Lane, D. A., Lip, G. Y. H., Harris, R. V., Mughal, A., & Weir, C. (2023). Screening of atrial fibrillation in dental practices: a qualitative feasibility study.. Expert review of cardiovascular therapy. doi:10.1080/14779072.2023.2254679DOI: 10.1080/14779072.2023.2254679
Qvist, I., Lane, D. A., Risom, S. S., Hendriks, J. M., Hojen, A. A., Johnsen, S. P., & Frost, L. (2023). Implementation of patient education for patients with atrial fibrillation: nationwide cross-sectional survey and one-year follow-up. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING. doi:10.1093/eurjcn/zvad066DOI: 10.1093/eurjcn/zvad066
Proietti, R., Rivera-Caravaca, J. M., Lopez-Galvez, R., Harrison, S. L., Buckley, B. J. R., Marin, F., . . . Lip, G. Y. H. (2023). Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. CLINICAL CARDIOLOGY, 46(6), 656-662. doi:10.1002/clc.24006DOI: 10.1002/clc.24006
Savelieva, I., Fumagalli, S., Kenny, R. A., Anker, S., Benetos, A., Boriani, G., . . . Grodzicki, T. (2023). EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 25(4), 1249-1276. doi:10.1093/europace/euac123DOI: 10.1093/europace/euac123
Proietti, R., Rivera-Caravaza, J. M., Lopez-Galvez, R., Harrison, S. L., Marin, F., Underhill, P., . . . Lip, G. (n.d.). Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 12(8). doi:10.3390/jcm12082814DOI: 10.3390/jcm12082814
An Empowerment Toolbox for Older People with Atrial Fibrillation: Results: from the AFFIRMO project (Conference Paper)
Graffigna, G., Anderson, G., Bosio, C., De Vita, M., Kalra, D., Lane, D., . . . Trevisa, C. (2023). An Empowerment Toolbox for Older People with Atrial Fibrillation: Results: from the AFFIRMO project. In PATIENT EDUCATION AND COUNSELING Vol. 109 (pp. 131). doi:10.1016/j.pec.2022.10.300DOI: 10.1016/j.pec.2022.10.300
Uruthirakumar, P., Surenthirakumaran, R., Gooden, T., Lip, G. Y. H., Thomas, G. N., Moore, D., . . . Guruparan, M. (2023). The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review. SYSTEMATIC REVIEWS, 12(1). doi:10.1186/s13643-023-02197-2DOI: 10.1186/s13643-023-02197-2
Hydes, T. J., Lip, G. Y. H., & Lane, D. A. (2023). Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Circulation, 147(10), 795-797. doi:10.1161/circulationaha.122.063195DOI: 10.1161/circulationaha.122.063195
Ding, W. Y., Blomstrom-Lundqvist, C., Fauchier, L., Marin, F., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2023). Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 25(2), 277-282. doi:10.1093/europace/euac214DOI: 10.1093/europace/euac214
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2023). Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry. EUROPACE, 25(2), 308-317. doi:10.1093/europace/euac153DOI: 10.1093/europace/euac153
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (Journal article)
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (2023). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 505. doi:10.1093/europace/euac251DOI: 10.1093/europace/euac251
Alobaida, M., Lip, G. Y. H., Lane, D. A., Sagris, D., Hill, A., & Harrison, S. L. (n.d.). Endovascular treatment for ischaemic stroke patients with and without atrial fibrillation, and the effects of adjunctive pharmacotherapy: a narrative review.. Expert Opin Pharmacother. doi:10.1080/14656566.2022.2161362DOI: 10.1080/14656566.2022.2161362
Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review. (Journal article)
Al Bahhawi, T., Aqeeli, A., Harrison, S. L., Lane, D. A., Skjøth, F., Buchan, I., . . . Lip, G. Y. H. (2023). Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review.. Journal of clinical medicine, 12(4), 1316. doi:10.3390/jcm12041316DOI: 10.3390/jcm12041316
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists (Conference Paper)
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists. In JOURNAL OF CLINICAL MEDICINE Vol. 12. doi:10.3390/jcm12031141DOI: 10.3390/jcm12031141
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists.. Journal of clinical medicine, 12(3), 1141. doi:10.3390/jcm12031141DOI: 10.3390/jcm12031141
AbuElkhair, A., Boidin, M., Buckley, B. J. R., Lane, D. A., Williams, N. H., Thijssen, D., . . . Barraclough, D. L. (2023). Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis.. Journal of cardiovascular medicine (Hagerstown, Md.), 24(2), 87-95. doi:10.2459/jcm.0000000000001386DOI: 10.2459/jcm.0000000000001386
Alobaida, M., Harrison, S. L., Lane, D. A., Underhill, P., Hill, A., & Lip, G. Y. H. (2023). Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: Impact of atrial fibrillation. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 32(2). doi:10.1016/j.jstrokecerebrovasdis.2022.106917DOI: 10.1016/j.jstrokecerebrovasdis.2022.106917
Harrison, S., Buckley, B., Lane, D., Fazio-Eynullayeva, E., Underhill, P., Hill, A., . . . Lip, G. (n.d.). Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-023-07433-4DOI: 10.1007/s10557-023-07433-4
1208 FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY (Journal article)
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2023). 1208 FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY. Age and Ageing, 52(Supplement_1). doi:10.1093/ageing/afac322.006DOI: 10.1093/ageing/afac322.006
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J. P., . . . Lane, D. A. (n.d.). Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study. British Journal of General Practice, BJGP.2022.0156. doi:10.3399/bjgp.2022.0156DOI: 10.3399/bjgp.2022.0156
Leo, D. G., Ozdemir, H., Lane, D., Lip, G., Keller, S., & Proietti, R. (n.d.). At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2023.1171647DOI: 10.3389/fcvm.2023.1171647
CARDIAC RHYTHM MONITORING TO SEARCH FOR ATRIAL FIBRILLATION AFTER STROKE: OPINIONS OF UK STROKE CLINICIANS (Conference Paper)
Cameron, A., Dawson, J., Price, C., Shaw, L., Wu, O., Smith, C., . . . Lane, D. (2023). CARDIAC RHYTHM MONITORING TO SEARCH FOR ATRIAL FIBRILLATION AFTER STROKE: OPINIONS OF UK STROKE CLINICIANS. In INTERNATIONAL JOURNAL OF STROKE Vol. 18 (pp. 28). Retrieved from https://www.webofscience.com/
FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY (Conference Paper)
Ritchie, L. A., Penson, R. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2023). FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY. In AGE AND AGEING Vol. 52. Retrieved from https://www.webofscience.com/
Therapy working hours, what works best in the hyperacute setting? (Conference Paper)
Harrison, S., Buckley, B., Lane, D., Chatterjee, K., Sagris, D., Joddrell, M., . . . Lip, G. (2023). Therapy working hours, what works best in the hyperacute setting?. In INTERNATIONAL JOURNAL OF STROKE Vol. 18 (pp. 115-116). Retrieved from https://www.webofscience.com/
2022
Paschoal, E., Gooden, T. E., Olmos, R. D., Lotufo, P. A., Benseñor, I. M., Manaseki-Holland, S., . . . Zhong, J. (n.d.). Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study. BMC Cardiovascular Disorders, 22(1). doi:10.1186/s12872-022-02927-9DOI: 10.1186/s12872-022-02927-9
Harrison, S. L., Buckley, B. J. R., Zheng, Y., Hill, A., Hlaing, T., Davies, R., . . . Jones, I. (2022). Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. American Heart Journal. doi:10.1016/j.ahj.2022.12.004DOI: 10.1016/j.ahj.2022.12.004
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018. AGE AND AGEING, 51(12). doi:10.1093/ageing/afac252DOI: 10.1093/ageing/afac252
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2022). Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist. AMERICAN JOURNAL OF MEDICINE, 135(12), 1410-1426. doi:10.1016/j.amjmed.2022.07.014DOI: 10.1016/j.amjmed.2022.07.014
Kanesamoorthy, S., Sheron, V. A., Uruthirakumar, P., Kodippily, C., Kumarendran, B., Gooden, T. E., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2022). Prevalence of atrial fibrillation in Northern Sri Lanka: a study protocol for a cross-sectional household survey.. BMJ open, 12(11), e056480. doi:10.1136/bmjopen-2021-056480DOI: 10.1136/bmjopen-2021-056480
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry (Journal article)
Boriani, G., Vitolo, M., Malavasi, V. L., Proietti, M., Fantecchi, E., Diemberger, I., . . . Lipand, G. Y. H. (2022). Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(15), 1967-1981. doi:10.1093/eurjpc/zwac115DOI: 10.1093/eurjpc/zwac115
Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., . . . Lane, D. A. (2022). Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis. JOURNAL OF MEDICAL INTERNET RESEARCH, 24(11). doi:10.2196/35508DOI: 10.2196/35508
Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial (Journal article)
Guo, Y., Romiti, G. F., Proietti, M., Bonini, N., Zhang, H., & Lip, G. Y. H. (2022). Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial. AGE AND AGEING, 51(11). doi:10.1093/ageing/afac245DOI: 10.1093/ageing/afac245
Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry (Journal article)
Vitolo, M., Proietti, M., Malavasi, V. L., Bonini, N., Romiti, G. F., Imberti, J. F., . . . Boriani, G. (2022). Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 105, 54-62. doi:10.1016/j.ejim.2022.08.004DOI: 10.1016/j.ejim.2022.08.004
Editorial: Mechanism and prevention of atrial fibrillation (Journal article)
Li, G., Lane, D. A., Tatjana, P. S., & Li, Y. (2022). Editorial: Mechanism and prevention of atrial fibrillation. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1066542DOI: 10.3389/fcvm.2022.1066542
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (Journal article)
Proietti, M., Romiti, G. F., Vitolo, M., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2022). Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(7), 778-786. doi:10.1093/ehjqcco/qcab069DOI: 10.1093/ehjqcco/qcab069
Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (Journal article)
Boriani, G., Vitolo, M., Proietti, M., Malavasi, V. L., Bonini, N., Romiti, G. F., . . . Lip, G. Y. H. (2022). Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry. European Heart Journal, 43(Supplement_2). doi:10.1093/eurheartj/ehac544.497DOI: 10.1093/eurheartj/ehac544.497
Associations between pregnancy complications and incident cardiovascular disease: a nationwide data linkage study in Wales (Conference Paper)
Al Bahhawi, T., Harrison, S. L., Lane, D. A., Buchan, I., Skjoth, F., Sharp, A., . . . Lip, G. Y. H. (2022). Associations between pregnancy complications and incident cardiovascular disease: a nationwide data linkage study in Wales. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 524). Retrieved from https://www.webofscience.com/
Factors associated with prescription of oral anticoagulation for atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018 (Journal article)
Ritchie, L., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2022). Factors associated with prescription of oral anticoagulation for atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018. EUROPEAN HEART JOURNAL, 43, 617. Retrieved from https://www.webofscience.com/
Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General (Conference Paper)
Vitolo, M., Proietti, M., Bonini, N., Romiti, G. F., Fauchier, L., Marin, F., . . . Boriani, G. (2022). Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 637). Retrieved from https://www.webofscience.com/
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry (Conference Paper)
Ding, W. Y., Lane, D. A., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 516). Retrieved from https://www.webofscience.com/
Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: impact of atrial fibrillation (Conference Paper)
Alobaida, M., Harrison, S. L., Lane, D. A., Hill, A., & Lip, G. Y. H. (2022). Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: impact of atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 551). Retrieved from https://www.webofscience.com/
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018. EUROPEAN HEART JOURNAL, 43, 2543. Retrieved from https://www.webofscience.com/
Role of multiple- and single-pregnancy complications with incident cardiovascular diseases: a nationwide data linkage study in Wales (Conference Paper)
Al Bahhawi, T., Harrison, S. L., Lane, D. A., Buchan, I., Skjoth, F., Sharp, A., . . . Lip, G. Y. H. (2022). Role of multiple- and single-pregnancy complications with incident cardiovascular diseases: a nationwide data linkage study in Wales. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 2516). Retrieved from https://www.webofscience.com/
Stroke-heart syndrome: sex-specific incidence, risk factors, and major adverse cardiovascular events in 486,515 patients with incident ischaemic stroke (Conference Paper)
Buckley, B. J. R., Harrison, S., Hill, A., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Stroke-heart syndrome: sex-specific incidence, risk factors, and major adverse cardiovascular events in 486,515 patients with incident ischaemic stroke. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 2323). Retrieved from https://www.webofscience.com/
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper (Journal article)
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. THROMBOSIS AND HAEMOSTASIS, 122(10), 1625-1652. doi:10.1055/s-0042-1750385DOI: 10.1055/s-0042-1750385
Ivany, E., Ritchie, L. A., Lip, G. Y. H., Lotto, R. R., Werring, D. J., & Lane, D. A. (2022). Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis. STROKE, 53(10), 3035-3046. doi:10.1161/STROKEAHA.122.038752DOI: 10.1161/STROKEAHA.122.038752
Santos, I. S., Lotufo, P. A., Goulart, A. C., Brant, L. C. C., Pinto Filho, M. M., Pereira, A. C., . . . Zhong, J. (2022). Cardiovascular Health and Atrial Fibrillation or Flutter: A Cross-Sectional Study from ELSA-Brasil.. Arquivos brasileiros de cardiologia, S0066-782X2022005016205. doi:10.36660/abc.20210970DOI: 10.36660/abc.20210970
Ritchie, L. A., Gordon, A. L., Penson, P. E., Lane, D. A., & Akpan, A. (2022). Stop and Go: Barriers and Facilitators to Care Home Research. JOURNAL OF FRAILTY & AGING, 12(1), 63-66. doi:10.14283/jfa.2022.51DOI: 10.14283/jfa.2022.51
Romiti, G. F., Proietti, M., Vitolo, M., Bonini, N., Fawzy, A. M., Ding, W. Y., . . . Lip, G. Y. H. (2022). Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC MEDICINE, 20(1). doi:10.1186/s12916-022-02526-7DOI: 10.1186/s12916-022-02526-7
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression (Conference Paper)
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Di Rocco, A., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. In EUROPEAN JOURNAL OF INTERNAL MEDICINE Vol. 103 (pp. 84-94). doi:10.1016/j.ejim.2022.06.023DOI: 10.1016/j.ejim.2022.06.023
Slade, A., O'Hara, M., Quinn, D., Marley, L., Griffith, S., Calvert, M., . . . Lane, D. (2022). Living with a left ventricular assist device: Capturing recipients experiences using group concept mapping software. PLOS ONE, 17(9). doi:10.1371/journal.pone.0273108DOI: 10.1371/journal.pone.0273108
Harrison, S. L., Lip, G. Y. H., Akbari, A., Torabi, F., Ritchie, L. A., Akpan, A., . . . Lane, D. A. (2022). Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 23(9), 1548-+. doi:10.1016/j.jamda.2022.05.003DOI: 10.1016/j.jamda.2022.05.003
Sheron, V. A., Shanmugathas, S., Gooden, T. E., Guruparan, M., Kumarendran, B., Lip, G. Y. H., . . . Beane, A. (2022). Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care. BMC HEALTH SERVICES RESEARCH, 22(1). doi:10.1186/s12913-022-08440-1DOI: 10.1186/s12913-022-08440-1
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe (Journal article)
Proietti, M., Romiti, G. F., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., . . . Lip, G. Y. H. (2022). Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. AGE AND AGEING, 51(8). doi:10.1093/ageing/afac192DOI: 10.1093/ageing/afac192
Ding, W. Y., Lane, D. A., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(15). doi:10.1161/JAHA.122.026410DOI: 10.1161/JAHA.122.026410
Nielsen, P. B., Melgaard, L., Overvad, T. F., Jensen, M., Larsen, T. B., & Lip, G. Y. H. (2022). Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 53(8), 2559-2568. doi:10.1161/STROKEAHA.121.038331DOI: 10.1161/STROKEAHA.121.038331
Bensenor, I. M., Goulart, A. C., Thomas, G. N., Lip, G. Y. H., Arasalingam, A., Beane, A., . . . Fi, N. I. H. R. G. H. R. G. A. (2022). Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 55(1). doi:10.1590/1414-431X2022e12369DOI: 10.1590/1414-431X2022e12369
Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants (Journal article)
Ritchie, L. A., Lane, D. A., & Lip, G. Y. H. (2022). Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. EUROPACE, 24(6), 871-873. doi:10.1093/europace/euab313DOI: 10.1093/europace/euab313
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Rocco, A. D., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. European Journal of Internal Medicine, 103, 84-94. doi:10.1016/j.ejim.2022.06.023DOI: 10.1016/j.ejim.2022.06.023
Lip, G. Y. H., Lane, D. A., Lenarczyk, R., Boriani, G., Doehner, W., Benjamin, L. A., . . . Potpara, T. (2022). Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. EUROPEAN HEART JOURNAL, 43(26), 2442-2460. doi:10.1093/eurheartj/ehac245DOI: 10.1093/eurheartj/ehac245
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke. CEREBROVASCULAR DISEASES, 51(4), 488-492. doi:10.1159/000521025DOI: 10.1159/000521025
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry (Journal article)
Malavasi, V. L., Vitolo, M., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . Boriani, G. (2022). Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(7). doi:10.1111/eci.13773DOI: 10.1111/eci.13773
Buckley, B. J. R., Lane, D. A., Calvert, P., Zhang, J., Gent, D., Mullins, C. D., . . . Lip, G. Y. H. (2022). Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE, 11(13). doi:10.3390/jcm11133788DOI: 10.3390/jcm11133788
Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry (Journal article)
Ding, W. Y., Boriani, G., Marin, F., Blomstrom-Lundqvist, C., Potpara, T. S., Fauchier, L., & Lip, G. Y. H. (2022). Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8(4), 372-382. doi:10.1093/ehjcvp/pvab076DOI: 10.1093/ehjcvp/pvab076
ARTIFICIAL INTELLIGENCE FACILITATES MONITORING OF PATIENTS WITH HEART FAILURE IN THE LANCASHIRE OBJECTIVE VOLUME EVALUATION OF LEG OEDEMA IN HEART FAILURE PILOT RANDOMISED CROSS-OVER TRIAL (LOVE-HF) (Conference Paper)
Awad, R., Abdullah, A., Assaf, O., Jones, R. L., Seed, A., Cassidy, C. J., . . . Wong, K. (2022). ARTIFICIAL INTELLIGENCE FACILITATES MONITORING OF PATIENTS WITH HEART FAILURE IN THE LANCASHIRE OBJECTIVE VOLUME EVALUATION OF LEG OEDEMA IN HEART FAILURE PILOT RANDOMISED CROSS-OVER TRIAL (LOVE-HF). In HEART Vol. 108 (pp. A86-A87). doi:10.1136/heartjnl-2022-BCS.116DOI: 10.1136/heartjnl-2022-BCS.116
PREVENTING STROKE IN PATIENTS WITH ATRIAL FIBRILLATION AND INTRACEREBRAL HAEMORRHAGE: A QUALITATIVE STUDY OF PHYSICIANS' DECISION-MAKING (Conference Paper)
Ivany, E., Lotto, R. R., Lip, G., & Lane, D. A. (2022). PREVENTING STROKE IN PATIENTS WITH ATRIAL FIBRILLATION AND INTRACEREBRAL HAEMORRHAGE: A QUALITATIVE STUDY OF PHYSICIANS' DECISION-MAKING. In HEART Vol. 108 (pp. A57-A58). doi:10.1136/heartjnl-2022-BCS.77DOI: 10.1136/heartjnl-2022-BCS.77
Harrison, S. L., Buckley, B. J. R., Ritchie, L. A., Proietti, R., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Oral anticoagulants and outcomes in adults >= 80 years with atrial fibrillation: A global federated health network analysis. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.17884DOI: 10.1111/jgs.17884
Calvert, P., Lip, G. Y. H., & Lane, D. A. (2022). Mental health and anticoagulant prescription in atrial fibrillation. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(3), 235-237. doi:10.1093/ehjqcco/qcab085DOI: 10.1093/ehjqcco/qcab085
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (Journal article)
Ding, W. Y., Proietti, M., Boriani, G., Fauchier, L., Blomstrom-Lundqvist, C., Marin, F., . . . Lip, G. Y. H. (2022). Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 24(5), 721-728. doi:10.1093/europace/euab280DOI: 10.1093/europace/euab280
Vitolo, M., Malavasi, V. L., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . ESC-EHRA EORP-AF Long-Term General Registry Investigators. (2022). Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry.. European journal of internal medicine, 99, 45-56. doi:10.1016/j.ejim.2022.01.025DOI: 10.1016/j.ejim.2022.01.025
Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Duncker, D., . . . Linz, D. (2022). Mobile health solutions for atrial fibrillation detection and management: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 111(5), 479-491. doi:10.1007/s00392-021-01941-9DOI: 10.1007/s00392-021-01941-9
Buckley, B. J. R., Harrison, S. L., Hill, A., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke. STROKE, 53(5), 1759-1763. doi:10.1161/STROKEAHA.121.037316DOI: 10.1161/STROKEAHA.121.037316
Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: A rapid evaluation of barriers and facilitators to care (Preprint)
DOI: 10.21203/rs.3.rs-1535559/v1
Gooden, T. E., Gardner, M., Wang, J., Jolly, K., Lane, D. A., Benjamin, L. A., . . . Thomas, G. N. (2022). Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study. JOURNAL OF INFECTIOUS DISEASES, 225(8), 1348-1356. doi:10.1093/infdis/jiab420DOI: 10.1093/infdis/jiab420
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2022). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol. JOURNAL OF PERSONALIZED MEDICINE, 12(4). doi:10.3390/jpm12040578DOI: 10.3390/jpm12040578
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE. doi:10.1093/europace/euac020DOI: 10.1093/europace/euac020
Ivany, E., Lotto, R., Lip, G. Y., & Lane, D. (2022). Managing uncertainty: Physicians' decision-making for stroke prevention for patients with atrial fibrillation and intracerebral haemorrhage.. Thrombosis and haemostasis. doi:10.1055/a-1789-4824DOI: 10.1055/a-1789-4824
Ritchie, L. A., Penson, P. E., & Lane, D. A. (2022). Warfarin-Is Self-Care the Best Care?. THROMBOSIS AND HAEMOSTASIS. doi:10.1055/s-0042-1742363DOI: 10.1055/s-0042-1742363
Abstract WP83: The Challenges Of Stroke Prevention Following Intracerebral Haemorrhage; A Qualitative Study Exploring Physicians’ Decision Making. (Journal article)
Ivany, E., Lotto, R. R., Lip, G. Y., & Lane, D. A. (2022). Abstract WP83: The Challenges Of Stroke Prevention Following Intracerebral Haemorrhage; A Qualitative Study Exploring Physicians’ Decision Making.. Stroke, 53(Suppl_1). doi:10.1161/str.53.suppl_1.wp83DOI: 10.1161/str.53.suppl_1.wp83
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2022). Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022. doi:10.1155/2022/5951262DOI: 10.1155/2022/5951262
Ding, W. Y., Potpara, T. S., Blomstrom-Lundqvist, C., Boriani, G., Marin, F., Fauchier, L., . . . Reg, E. S. C. -E. H. R. A. E. O. R. P. -A. F. L. -T. G. (2022). Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.13745DOI: 10.1111/eci.13745
Farkowski, M. M., Karlinski, M., Barra, S., Providencia, R., Golicki, D., Pytkowski, M., . . . Boveda, S. (2022). Effectiveness and safety of a single freeze strategy of cryoballoon ablation of atrial fibrillation: an EHRA systematic review and meta-analysis.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(1), 58-69. doi:10.1093/europace/euab133DOI: 10.1093/europace/euab133
Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (Conference Paper)
Boriani, G., Vitolo, M., Proietti, M., Malavasi, V. L., Bonini, N., Romiti, G. F., . . . Lip, G. Y. H. (2022). Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 497). Retrieved from https://www.webofscience.com/
Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study (Conference Paper)
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2022). Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 615). Retrieved from https://www.webofscience.com/
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2022). Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. CLINICAL RESEARCH IN CARDIOLOGY, 111(1), 70-84. doi:10.1007/s00392-021-01914-yDOI: 10.1007/s00392-021-01914-y
Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the AF-GEN-UK registry (Conference Paper)
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2022). Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the AF-GEN-UK registry. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 2227). Retrieved from https://www.webofscience.com/
Systolic blood pressure and renal function impact on clinical outcomes in patients with atrial fibrillation: Results from the AF-GEN-UK registry (Conference Paper)
Shantsila, A., Lip, G., & Lane, D. (2022). Systolic blood pressure and renal function impact on clinical outcomes in patients with atrial fibrillation: Results from the AF-GEN-UK registry. In JOURNAL OF HUMAN HYPERTENSION Vol. 36 (pp. 19). Retrieved from https://www.webofscience.com/
Harrison, S. L., Lane, D. A., Buckley, B. J. R., Chatterjee, K., Alobaida, M., Shipley, E., & Lip, G. Y. H. (2022). The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke. VASCULAR HEALTH AND RISK MANAGEMENT, 18, 313-318. doi:10.2147/VHRM.S357829DOI: 10.2147/VHRM.S357829
2021
Varma, N., Cygankiewicz, I., Turakhia, M., Heidbuchel, H., Hu, Y., Chen, L. Y., . . . Svennberg, E. (2021). Erratum: <b>Erratum to:</b> 2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society.. European heart journal. Digital health, 2(4), 727. doi:10.1093/ehjdh/ztab086DOI: 10.1093/ehjdh/ztab086
Stevens, D., Lane, D. A., Harrison, S. L., Lip, G. Y. H., & Kolamunnage-Dona, R. (2021). Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review. BMC MEDICAL RESEARCH METHODOLOGY, 21(1). doi:10.1186/s12874-021-01472-xDOI: 10.1186/s12874-021-01472-x
Interactive remote patient monitoring devices for managing chronic health conditions: systematic review and meta-analysis (Preprint) (Preprint)
DOI: 10.2196/preprints.35508
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general longterm registry (Conference Paper)
Vitolo, M., Malavasi, V. L., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . Boriani, G. (2021). Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general longterm registry. In EUROPEAN HEART JOURNAL SUPPLEMENTS Vol. 23. doi:10.1093/eurheartj/suab127.052DOI: 10.1093/eurheartj/suab127.052
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression (Conference Paper)
Borgi, M., Proietti, M., Romiti, G. F., Vitolo, M., Di Rocco, A., Farcomeni, A., . . . Lip, G. Y. H. (2021). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression. In EUROPEAN HEART JOURNAL SUPPLEMENTS Vol. 23 (pp. G3-+). doi:10.1093/eurheartj/suab127.002DOI: 10.1093/eurheartj/suab127.002
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression (Conference Paper)
Borgi, M., Proietti, M., Romiti, G. F., Vitolo, M., Di Rocco, A., Farcomeni, A., . . . Lip, G. Y. H. (2021). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression. In EUROPEAN HEART JOURNAL SUPPLEMENTS Vol. 23. Retrieved from https://www.webofscience.com/
Anticoagulation control in atrial fibrillation patients with chronic kidney disease receiving warfarin for stroke prevention: The west Birmingham AF project (Conference Paper)
Zulkifly, H. H., Lip, G. Y. H., & Lane, D. A. (2021). Anticoagulation control in atrial fibrillation patients with chronic kidney disease receiving warfarin for stroke prevention: The west Birmingham AF project. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 345 (pp. 17). doi:10.1016/j.ijcard.2021.10.065DOI: 10.1016/j.ijcard.2021.10.065
Yao, Y., Guo, Y., & Lip, G. Y. H. (2021). The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity The mAFA-II Randomized Clinical Trial. JAMA NETWORK OPEN, 4(12). doi:10.1001/jamanetworkopen.2021.40071DOI: 10.1001/jamanetworkopen.2021.40071
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., . . . Watkins, C. L. (2021). Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.. European heart journal, 42(40), 4194. doi:10.1093/eurheartj/ehab648DOI: 10.1093/eurheartj/ehab648
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2021). Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-02120-3DOI: 10.1186/s12916-021-02120-3
Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study (Journal article)
Greaves, O., Harrison, S. L., Lane, D. A., Banach, M., Mastej, M., Jozwiak, J. J., & Lip, G. Y. H. (2021). Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.2471DOI: 10.1093/eurheartj/ehab724.2471
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-analysis (Journal article)
Romiti, G. F., Corica, B., Borgi, M., Vitolo, M., Miyazawa, K., Healey, J. S., . . . Proietti, M. (2021). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-analysis. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.0419DOI: 10.1093/eurheartj/ehab724.0419
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry (Journal article)
Malavasi, V. L., Vitolo, M., Proietti, M., Fauchier, L., Marin, F., Nabauer, M., . . . Boriani, G. (2021). Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.2862DOI: 10.1093/eurheartj/ehab724.2862
Pharmacist management of atrial fibrillation: a pilot educational intervention study (Journal article)
Al-Arkee, S., Mason, J., Fabritz, L., Chua, W., Lane, D. A., & Jalal, Z. (2021). Pharmacist management of atrial fibrillation: a pilot educational intervention study. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.0544DOI: 10.1093/eurheartj/ehab724.0544
Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review (Journal article)
Shahid, M. Z., Singh, H., Lane, D. A., Logantha, S. J. R. J., Lip, G. Y. H., & Harrison, S. L. (2021). Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.0568DOI: 10.1093/eurheartj/ehab724.0568
Using group concept mapping software to develop a conceptual framework of left ventricular assist device recipients' experiences (Journal article)
Slade, A. L., O'Hara, M. E., Quinn, D., Marley, L., Griffith, S., Haque, M. S., . . . Lane, D. A. (2021). Using group concept mapping software to develop a conceptual framework of left ventricular assist device recipients' experiences. European Heart Journal, 42(Supplement_1). doi:10.1093/eurheartj/ehab724.0948DOI: 10.1093/eurheartj/ehab724.0948
Phrommintikul, A., Nathisuwan, S., Gunaparn, S., Krittayaphong, R., Wongcharoen, W., Sehmi, S., . . . Lip, G. Y. H. (2021). Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ OPEN, 11(10). doi:10.1136/bmjopen-2021-051987DOI: 10.1136/bmjopen-2021-051987
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Journal article)
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., . . . Field, M. (2021). 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EUROPACE, 23(10), 1612-1676. doi:10.1093/europace/euab065DOI: 10.1093/europace/euab065
Stevens, D., Harrison, S. L., Kolamunnage-Dona, R., Lip, G. Y. H., & Lane, D. A. (2021). The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review. EUROPACE, 23(10), 1511-1527. doi:10.1093/europace/euab092DOI: 10.1093/europace/euab092
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Lane, D., & Lip, G. (2021). Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. European Journal of Clinical Investigation.
Rashidi, A., Whitehead, L., Newson, L., Astin, F., Gill, P., Lane, D. A., . . . Jones, I. D. (2021). The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(15). doi:10.3390/ijerph18158126DOI: 10.3390/ijerph18158126
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Lane, D., Thijssen, D., & Lip, G. (n.d.). Exercise-based cardiac rehabilitation and all-cause mortality among patients with atrial fibrillation. Journal of the American Heart Association.
LANCASHIRE OBJECTIVE VOLUME EVALUATION OF LEG OEDEMA IN HEART FAILURE RANDOMIZED CONTROLLED CROSS-OVER TRIALS (LOVE-HF ARTIFICIAL INTELLIGENCE RESEARCH PROGRAMME): RATIONALE AND METHODOLOGY (Conference Paper)
Awad, R., Jones, R., Assaf, O., Abdullah, A., Seed, A., Cassidy, C. J., . . . Wong, K. (2021). LANCASHIRE OBJECTIVE VOLUME EVALUATION OF LEG OEDEMA IN HEART FAILURE RANDOMIZED CONTROLLED CROSS-OVER TRIALS (LOVE-HF ARTIFICIAL INTELLIGENCE RESEARCH PROGRAMME): RATIONALE AND METHODOLOGY. In HEART Vol. 107 (pp. A100-A102). doi:10.1136/heartjnl-2021-BCS.131DOI: 10.1136/heartjnl-2021-BCS.131
Al-Arkee, S., Mason, J., Lane, D. A., Fabritz, L., Chua, W., Haque, M. S., & Jalal, Z. (2021). Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis. JOURNAL OF MEDICAL INTERNET RESEARCH, 23(5). doi:10.2196/24190DOI: 10.2196/24190
Associations of exercise-based cardiac rehabilitation with all-cause mortality among patients with atrial fibrillation (Journal article)
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Lane, D., Thijssen, D., & Lip, G. (2021). Associations of exercise-based cardiac rehabilitation with all-cause mortality among patients with atrial fibrillation. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.505DOI: 10.1093/europace/euab116.505
Impact on outcomes in Europe: a cluster analysis from the ESC-EHRA EORP AF general long-term registry (Journal article)
Proietti, M., Vitolo, M., Harrison, S., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2021). Impact on outcomes in Europe: a cluster analysis from the ESC-EHRA EORP AF general long-term registry. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.301DOI: 10.1093/europace/euab116.301
Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2021). Subclinical thyroid dysfunction and incident atrial fibrillation - a systematic review and meta-analysis. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.153DOI: 10.1093/europace/euab116.153
Ivany, E., Lane, D. A., Dan, G. -A., Doehner, W., Farkowski, M. M., Iliodromitis, K., . . . Potpara, T. S. (n.d.). Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey. EP Europace. doi:10.1093/europace/euaa423DOI: 10.1093/europace/euaa423
Varma, N., Cygankiewicz, I., Turakhia, M., Heidbuchel, H., Hu, Y., Chen, L. Y., . . . Svennberg, E. (2021). 2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society.. European heart journal. Digital health, 2(1), 7-48. doi:10.1093/ehjdh/ztab001DOI: 10.1093/ehjdh/ztab001
Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications (Journal article)
Harrison, S. L., Buckley, B. J. R., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. PHARMACOLOGICAL RESEARCH, 167. doi:10.1016/j.phrs.2021.105534DOI: 10.1016/j.phrs.2021.105534
Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i> (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrom-Lundqvist, C., . . . Watkins, C. L. (2021). Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i>. REVISTA ESPANOLA DE CARDIOLOGIA, 74(5). doi:10.1016/j.recesp.2020.10.022DOI: 10.1016/j.recesp.2020.10.022
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Higher Mortality of Ischaemic Stroke Patients Hospitalized with COVID-19 Compared to Historical Controls. CEREBROVASCULAR DISEASES, 50(3), 326-331. doi:10.1159/000514137DOI: 10.1159/000514137
Vitolo, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2021). The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F81-F83. doi:10.1093/ehjcvp/pvaa020DOI: 10.1093/ehjcvp/pvaa020
Varma, N., Cygankiewicz, I., Turakhia, M., Heidbuchel, H., Hu, Y., Chen, L. Y., . . . Svennberg, E. (2021). 2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals. Journal of Arrhythmia, 37(2), 271-319. doi:10.1002/joa3.12461DOI: 10.1002/joa3.12461
Ritchie, L. A., Lip, G. Y. H., & Lane, D. A. (2021). Optimization of atrial fibrillation care: management strategies and quality measures. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(2), 121-133. doi:10.1093/ehjqcco/qcaa063DOI: 10.1093/ehjqcco/qcaa063
Varma, N., Cygankiewicz, I., Turakhia, M., Heidbuchel, H., Hu, Y., Chen, L. Y., . . . Svennberg, E. (2021). 2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society. JOURNAL OF ARRHYTHMIA, 37(2), 271-319. doi:10.1002/joa3.12461DOI: 10.1002/joa3.12461
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021) (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstroem-Lundqvist, C., . . . Watkins, C. L. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021). EUROPEAN HEART JOURNAL, 42(40), 4194. doi:10.1093/eurheartj/ehab648DOI: 10.1093/eurheartj/ehab648
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) (vol 42, pg 373, 2021) (Journal article)
Hindricks, G. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) (vol 42, pg 373, 2021). EUROPEAN HEART JOURNAL, 42(5), 507. doi:10.1093/eurheartj/ehaa798DOI: 10.1093/eurheartj/ehaa798
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) (vol 42, pg 373, 2021) (Journal article)
Hindricks, G. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) (vol 42, pg 373, 2021). EUROPEAN HEART JOURNAL, 42(5), 546-547. doi:10.1093/eurheartj/ehaa945DOI: 10.1093/eurheartj/ehaa945
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y., Chen, L. Y., . . . Svennberg, E. (2021). 2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals. CARDIOVASCULAR DIGITAL HEALTH JOURNAL, 2(1), 4-54. doi:10.1016/j.cvdhj.2020.11.004DOI: 10.1016/j.cvdhj.2020.11.004
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y. -F., Chen, L. Y., . . . Svennberg, E. (2021). 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 14(2), 234-283. doi:10.1161/CIRCEP.120.009204DOI: 10.1161/CIRCEP.120.009204
Boriani, G., Vitolo, M., Lane, D. A., Potpara, T. S., & Lip, G. Y. H. (2021). Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 86, 1-11. doi:10.1016/j.ejim.2021.01.006DOI: 10.1016/j.ejim.2021.01.006
Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey (Journal article)
Koenig, S., Svetlosak, M., Grabowski, M., Duncker, D., Nagy, V. K., Bogdan, S., . . . Kosiuk, J. (2021). Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey. EUROPACE, 23(1), 149-156. doi:10.1093/europace/euaa301DOI: 10.1093/europace/euaa301
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2021). Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 10(3). doi:10.3390/jcm10030435DOI: 10.3390/jcm10030435
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrӧm-Lundqvist, C., . . . Watkins, C. L. (n.d.). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology, 26(9), 4701. doi:10.15829/1560-4071-2021-4701DOI: 10.15829/1560-4071-2021-4701
2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals (Journal article)
Electrocardiology, F. T. I. S. F. H. A. N., Society, H. R., Association, E. H. R., & Society, A. P. H. R. (n.d.). 2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals. Russian Journal of Cardiology, 26, 4420. doi:10.15829/1560-4071-2021-4420DOI: 10.15829/1560-4071-2021-4420
Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study (Conference Paper)
Greaves, O., Harrison, S. L., Lane, D. A., Banach, M., Mastej, M., Jozwiak, J. J., & Lip, G. Y. H. (2021). Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 2471). Retrieved from https://www.webofscience.com/
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry (Conference Paper)
Malavasi, V. L., Vitolo, M., Proietti, M., Fauchier, L., Marin, F., Nabauer, M., . . . Boriani, G. (2021). Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 2862). Retrieved from https://www.webofscience.com/
Awad, R. R., Jones, R., Assaf, O., Abdullah, A., Seed, A., Cassidy, C., . . . Wong, K. (2021). Lancashire objective volume evaluation of leg oedema in heart failure (LOVE-HF): conceptualization of a novel end point. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 23 (pp. 94-95). Retrieved from https://www.webofscience.com/
OPTIMISATION OF ORAL ANTICOAGULATION FOR STROKE PREVENTION: A SCOPING REVIEW OF FACTORS INFLUENCING UPTAKE AND IMPLEMENTATION IN EFFECTIVENESS STUDIES (Conference Paper)
Gibson, J., Weldon, J., Banerjee, A., Chauhan, U., Georgiou, R., Joshi, M., . . . Watkins, C. (2021). OPTIMISATION OF ORAL ANTICOAGULATION FOR STROKE PREVENTION: A SCOPING REVIEW OF FACTORS INFLUENCING UPTAKE AND IMPLEMENTATION IN EFFECTIVENESS STUDIES. In INTERNATIONAL JOURNAL OF STROKE Vol. 16 (pp. 37). Retrieved from https://www.webofscience.com/
Pharmacist management of atrial fibrillation: a pilot educational intervention study (Conference Paper)
Al-Arkee, S., Mason, J., Fabritz, L., Chua, W., Lane, D. A., & Jalal, Z. (2021). Pharmacist management of atrial fibrillation: a pilot educational intervention study. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 544). Retrieved from https://www.webofscience.com/
Gooden, T., Gardner, M., Wang, J., Jolly, K., Lane, D. A., Benjamin, L. A., . . . Thomas, G. N. (2021). The association of cardiovascular risk factors and disease in people living with HIV in the United Kingdom: a retrospective matched cohort study. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY Vol. 24 (pp. 4-5). Retrieved from https://www.webofscience.com/
Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review (Conference Paper)
Shahid, M. Z., Singh, H., Lane, D. A., Logantha, S. J. R. J., Lip, G. Y. H., & Harrison, S. L. (2021). Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 568). Retrieved from https://www.webofscience.com/
Using group concept mapping software to develop a conceptual framework of left ventricular assist device recipients' experiences (Conference Paper)
Slade, A. L., O'Hara, M. E., Quinn, D., Marley, L., Griffith, S., Haque, M. S., . . . Lane, D. A. (2021). Using group concept mapping software to develop a conceptual framework of left ventricular assist device recipients' experiences. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 948). Retrieved from https://www.webofscience.com/
2020
Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review. (Journal article)
Ritchie, L. A., Oke, O. B., Harrison, S. L., Rodgers, S. E., Lip, G. Y. H., & Lane, D. A. (2021). Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.. Age and Ageing, 50(3), 744-757. doi:10.1093/ageing/afaa268DOI: 10.1093/ageing/afaa268
Santos, I. S., Goulart, A. C., Olmos, R. D., Thomas, G. N., Lip, G. Y. H., Lotufo, P. A., & Bensenor, I. M. (2020). Atrial fibrillation in low- and middle-income countries: a narrative review. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 61-77. doi:10.1093/eurheartj/suaa181DOI: 10.1093/eurheartj/suaa181
Lane, D. A., & Lip, G. Y. H. (2020). Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 14-27. doi:10.1093/eurheartj/suaa178DOI: 10.1093/eurheartj/suaa178
Harrison, S., Fazio-Eynullayeva, E., Lane, D., Underhill, P., & Lip, G. (2020). Atrial fibrillation and the risk of 30-day incident thromboembolic events and mortality in adults ≥50 years with COVID-19. Journal of Arrhythmia.
Harrison, S. L., Buckley, B. J. R., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2020). End-Stage Renal Disease and 30-day Mortality for Adults with and without COVID-19. European Journal of Internal Medicine. doi:10.1016/j.ejim.2020.11.003DOI: 10.1016/j.ejim.2020.11.003
Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry (Conference Paper)
Vitolo, M., Proietti, M., Harrison, S., Kalarus, Z., Tavazzi, L., Potpara, T., . . . Lip, G. Y. H. (2020). Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 2868). Retrieved from https://www.webofscience.com/
Increasing age as a major determinant of major adverse outcomes in patients with atrial fibrillation: the EURObservational research programme in atrial fibrillation general long-term registry (Conference Paper)
Boriani, G., Proietti, M., Laroche, C., Riot, O., Lane, D. A., Potpara, T., . . . Lip, G. Y. H. (2020). Increasing age as a major determinant of major adverse outcomes in patients with atrial fibrillation: the EURObservational research programme in atrial fibrillation general long-term registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 3224). Retrieved from https://www.webofscience.com/
Regular reassessment of bleeding risk using the HAS-BLED score reduces bleeding outcomes in a prospective cohort: a report from the mAFA II clinical trial extension (Conference Paper)
Guo, Y., Lane, D., Chen, Y., & Lip, G. Y. H. (2020). Regular reassessment of bleeding risk using the HAS-BLED score reduces bleeding outcomes in a prospective cohort: a report from the mAFA II clinical trial extension. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 644). Retrieved from https://www.webofscience.com/
Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry (Conference Paper)
Proietti, M., Vitolo, M., Harrison, S., Dan, G. A., Maggioni, A. P., Potpara, T., . . . Lip, G. Y. H. (2020). Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 2834). Retrieved from https://www.webofscience.com/
Temporal changes in quality of life amongst European atrial fibrillation patients: relationship to all-cause mortality. A report from the ESC-EHRA EORP-AF General Long-Term Registry (Conference Paper)
Vitolo, M., Proietti, M., Harrison, S., Fauchier, L., Marin, F., Potpara, T., . . . Lip, G. Y. H. (2020). Temporal changes in quality of life amongst European atrial fibrillation patients: relationship to all-cause mortality. A report from the ESC-EHRA EORP-AF General Long-Term Registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 682). Retrieved from https://www.webofscience.com/
The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study (Conference Paper)
Harrison, S., Lip, G. Y. H., Lane, D. A., Mastej, M., Kasperczyk, S., Banach, M., & Jozwiak, J. J. (2020). The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 451). Retrieved from https://www.webofscience.com/
Ivany, E., & Lane, D. A. (2020). Patient Satisfaction: A Key Component in Increasing Treatment Adherence and Persistence.. Thromb Haemost. doi:10.1055/s-0040-1718734DOI: 10.1055/s-0040-1718734
Pharmacist implementation of a treatment pathway for atrial fibrillation in care home residents (Dataset)
Ritchie, L., & Lane, D. (n.d.). Pharmacist implementation of a treatment pathway for atrial fibrillation in care home residents. doi:10.1186/isrctn14747952DOI: 10.1186/isrctn14747952
Lane, D. A. (2020). Homelessness: a 'cause of the causes' of cardiovascular disease?. HEART, 106(19), 1456-1457. doi:10.1136/heartjnl-2020-317224DOI: 10.1136/heartjnl-2020-317224
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. AMERICAN JOURNAL OF MEDICINE, 133(10), 1195-+. doi:10.1016/j.amjmed.2020.03.019DOI: 10.1016/j.amjmed.2020.03.019
Vitolo, M., Proietti, M., Harrison, S., Lane, D. A., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2020). The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years. INTERNAL AND EMERGENCY MEDICINE, 15(7), 1183-1192. doi:10.1007/s11739-020-02405-0DOI: 10.1007/s11739-020-02405-0
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020). Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLOS MEDICINE, 17(9). doi:10.1371/journal.pmed.1003321DOI: 10.1371/journal.pmed.1003321
Domek, M., Gumprecht, J., Ding, W. Y., Lip, G. Y. H., & Lane, D. A. (2020). Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(I), I1-I12. doi:10.1093/eurheartj/suaa100DOI: 10.1093/eurheartj/suaa100
Arbelo, E., Aktaa, S., Bollmann, A., D'Avila, A., Drossart, I., Dwight, J., . . . ESC Scientific Document Group. (2020). Quality indicators for the care and outcomes of adults with atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euaa253DOI: 10.1093/europace/euaa253
Lane, D. A., McMahon, N., Gibson, J., Weldon, J. C., Farkowski, M. M., Lenarczyk, R., . . . Potpara, T. S. (2020). Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review. EUROPACE, 22(10), 1567-1578. doi:10.1093/europace/euaa269DOI: 10.1093/europace/euaa269
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2020). Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation. Thrombosis Research. doi:10.1016/j.thromres.2020.04.001DOI: 10.1016/j.thromres.2020.04.001
Guo, J. D., Hlavacek, P., Poretta, T., Wygant, G., Lane, D., Gorritz, M., . . . Rosenblatt, L. (2020). Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States.. Journal of thrombosis and thrombolysis, 50(2), 386-394. doi:10.1007/s11239-019-02032-3DOI: 10.1007/s11239-019-02032-3
Guo, Y., Lip, G. Y. H., & Lane, D. A. (2020). Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more.. Trends in cardiovascular medicine. doi:10.1016/j.tcm.2020.03.007DOI: 10.1016/j.tcm.2020.03.007
Huppertz, N., Lip, G. Y. H., & Lane, D. A. (2020). Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY, 109(7), 802-809. doi:10.1007/s00392-019-01567-yDOI: 10.1007/s00392-019-01567-y
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2020). Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial. Journal of the American Heart Association, e014932. doi:10.1161/jaha.119.014932DOI: 10.1161/jaha.119.014932
Torp-Pedersen, C., Goette, A., Nielsen, P. B., Potpara, T., Fauchier, L., Camm, A. J., . . . Al-Khatib, S. M. (2020). 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). EUROPACE, 22(5), 831-+. doi:10.1093/europace/euz210DOI: 10.1093/europace/euz210
Pritchett, R. V., Clarke, J. L., Jolly, K., Clarkesmith, D., Bem, D., Turner, G. M., . . . Lane, D. A. (2020). Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis. PLOS ONE, 15(5). doi:10.1371/journal.pone.0232484DOI: 10.1371/journal.pone.0232484
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation". CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(5), 273-274. doi:10.1161/CIRCOUTCOMES.120.006635DOI: 10.1161/CIRCOUTCOMES.120.006635
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 41(17), 1617-1619. doi:10.1093/eurheartj/ehaa161DOI: 10.1093/eurheartj/ehaa161
Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot Survey (Journal article)
Lenarczyk, R., Boveda, S., Mansourati, J., Russo, V., Marijon, E., Lane, D. A., . . . Potpara, T. S. (2020). Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot Survey. EUROPACE, 22(5), 833-838. doi:10.1093/europace/euaa023DOI: 10.1093/europace/euaa023
McMahon, N. E., Bangee, M., Benedetto, V., Bray, E. P., Georgiou, R. F., Gibson, J. M. E., . . . Watkins, C. L. (2020). Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.. Stroke, STROKEAHA119027123. doi:10.1161/strokeaha.119.027123DOI: 10.1161/strokeaha.119.027123
Guo, Y., Lane, D. A., Wang, L., Zhang, H., Wang, H., Zhang, W., . . . Fulin, G. (2020). Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 75(13), 1523-1534. doi:10.1016/j.jacc.2020.01.052DOI: 10.1016/j.jacc.2020.01.052
Harrison, S. L., Lane, D. A., Guo, Y., & Lip, G. Y. H. (2020). The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection. EXPERT REVIEW OF MEDICAL DEVICES, 17(4), 253-255. doi:10.1080/17434440.2020.1740085DOI: 10.1080/17434440.2020.1740085
Ding, W. Y., Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(4), 788-790. doi:10.1111/jth.14738DOI: 10.1111/jth.14738
Seligman, W. H., Das-Gupta, Z., Jobi-Odeneye, A. O., Arbelo, E., Banerjee, A., Bollmann, A., . . . Camm, A. J. (2020). Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group. EUROPEAN HEART JOURNAL, 41(10), 1132-1140. doi:10.1093/eurheartj/ehz871DOI: 10.1093/eurheartj/ehz871
Ding, W. Y., Harrison, S., Gupta, D., Lip, G. Y. H., & Lane, D. A. (2020). Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies. FRONTIERS IN MEDICINE, 7. doi:10.3389/fmed.2020.00054DOI: 10.3389/fmed.2020.00054
Montalescot, G., Brotons, C., Cosyns, B., Crijns, H. J., D'Angelo, A., Drouet, L., . . . Darius, H. (2020). Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 20(1), 61-71. doi:10.1007/s40256-019-00356-2DOI: 10.1007/s40256-019-00356-2
Fanikos, J., Murwin, D., Gruenenfelder, F., Tartakovsky, I., França, L. R., Reilly, P. A., . . . Butcher, K. (2020). Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program.. Thrombosis and haemostasis, 120(1), 27-35. doi:10.1055/s-0039-1695771DOI: 10.1055/s-0039-1695771
Group concept mapping: capturing important patient-reported outcome domains for Left Ventricular Assist Device recipients (Conference Paper)
Slade, A., O'Hara, E., Quinn, D., Marley, L., Griffith, S., Calvert, M., . . . Lane, D. A. (2020). Group concept mapping: capturing important patient-reported outcome domains for Left Ventricular Assist Device recipients. In QUALITY OF LIFE RESEARCH Vol. 29 (pp. S39-S40). Retrieved from https://www.webofscience.com/
Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. EUROPEAN JOURNAL OF HEART FAILURE, 22(1), 136-138. doi:10.1002/ejhf.1685DOI: 10.1002/ejhf.1685
2019
Bray, E. P., McMahon, N. E., Bangee, M., Al-Khalidi, A. H., Benedetto, V., Chauhan, U., . . . Watkins, C. L. (2019). Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines. SYSTEMATIC REVIEWS, 8(1). doi:10.1186/s13643-019-1247-6DOI: 10.1186/s13643-019-1247-6
Depression, Anxiety, Knowledge, Beliefs About Medication and Quality of Life Among Newly Anticoagulated Atrial Fibrillation Patients (Conference Paper)
Zulkiflly, H. H., Lip, G. Y. H., & Lane, D. A. (2019). Depression, Anxiety, Knowledge, Beliefs About Medication and Quality of Life Among Newly Anticoagulated Atrial Fibrillation Patients. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 297 (pp. 19). doi:10.1016/j.ijcard.2019.11.052DOI: 10.1016/j.ijcard.2019.11.052
Guo, Y., Wang, H., Zhang, H., Liu, T., Liang, Z., Xia, Y., . . . Investigators, M. A. F. A. I. I. (2019). Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(19), 2365-2375. doi:10.1016/j.jacc.2019.08.019DOI: 10.1016/j.jacc.2019.08.019
Miyazawa, K., Ogawa, H., Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., . . . Lip, G. Y. H. (2019). Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2434-2442. doi:10.1253/circj.cj-19-0546DOI: 10.1253/circj.cj-19-0546
P2753Anticoagulation control and all-cause death in patients with operated valvular heart disease with and without atrial fibrillation receiving vitamin K antagonists (Journal article)
Zulkifly, H., Pastori, D., Lip, G. Y. H., & Lane, D. (2019). P2753Anticoagulation control and all-cause death in patients with operated valvular heart disease with and without atrial fibrillation receiving vitamin K antagonists. European Heart Journal, 40(Supplement_1). doi:10.1093/eurheartj/ehz748.1070DOI: 10.1093/eurheartj/ehz748.1070
Lip, G. Y. H., Guo, Y., Lotufo, P., Surenthirakumaran, R., Humphreys, L., Thomas, G. N., . . . Thomas, G. N. (2019). The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management. EUROPEAN HEART JOURNAL, 40(36), 3005-3007. doi:10.1093/eurheartj/ehz648DOI: 10.1093/eurheartj/ehz648
Cognitive Behavioral Therapy for Depression, Anxiety, and Stress in Caregivers of Dementia Patients: A Systematic Review and Meta-Analysis (Journal article)
Hopkinson, M. D., Reavell, J., Lane, D. A., & Mallikarjun, P. (2019). Cognitive Behavioral Therapy for Depression, Anxiety, and Stress in Caregivers of Dementia Patients: A Systematic Review and Meta-Analysis. GERONTOLOGIST, 59(4), E343-E362. doi:10.1093/geront/gnx217DOI: 10.1093/geront/gnx217
Lane, D. A., Dagres, N., Dan, G. -A., Garcia Seara, J., Iliodromitis, K., Lenarczyk, R., . . . Potpara, T. S. (2019). Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. EUROPACE, 21(7), 1116-1125. doi:10.1093/europace/euz033DOI: 10.1093/europace/euz033
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2019). Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. EUROPACE, 21(7), 1013-1022. doi:10.1093/europace/euz032DOI: 10.1093/europace/euz032
Guo, Y., Lane, D. A., Wang, L., Chen, Y., Lip, G. Y. H., Wang, L., . . . Ge, F. (2019). Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(7). doi:10.1111/ijcp.13352DOI: 10.1111/ijcp.13352
Højen, A. A., Søgaard, M., Melgaard, L., Lane, D. A., Sørensen, E. E., Goldhaber, S. Z., & Larsen, T. B. (2019). Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: A Danish nationwide cohort study. BMJ Open, 9(5). doi:10.1136/bmjopen-2018-026159DOI: 10.1136/bmjopen-2018-026159
Proietti, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2019). Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 619-633. doi:10.1016/j.cjca.2019.02.009DOI: 10.1016/j.cjca.2019.02.009
The Liverpool Centre for Cardiovascular Science. (Journal article)
Lip, G. Y. H., & Lane, D. A. (2019). The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally. EUROPEAN HEART JOURNAL, 40(12), 957-958. doi:10.1093/eurheartj/ehz107DOI: 10.1093/eurheartj/ehz107
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H., Chin, A., Coats, A., . . . EHRA Scientific Documents Committee. (2019). Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euz046DOI: 10.1093/europace/euz046
WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE (Conference Paper)
Hsu, J. C., Akao, M., Avezum Junior, A., Bloomfield, G., Kohsaka, S., Lane, D., . . . Maddox, T. (2019). WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 376). doi:10.1016/S0735-1097(19)30984-2DOI: 10.1016/S0735-1097(19)30984-2
Diener, H. -C., Hart, R. G., Koudstaal, P. J., Lane, D. A., & Lip, G. Y. H. (2019). Atrial Fibrillation and Cognitive Function <i>JACC</i> Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(5), 612-619. doi:10.1016/j.jacc.2018.10.077DOI: 10.1016/j.jacc.2018.10.077
Quinn, T. J., & Lane, D. A. (2019). Anticoagulation for Atrial Fibrillation in Older Adults-Using Big Data for Big Questions. THROMBOSIS AND HAEMOSTASIS, 119(6), 855-857. doi:10.1055/s-0039-1688482DOI: 10.1055/s-0039-1688482
Bangee, M., Bray, E. P., McMahon, N. E., Georgiou, R. F., Gibson, J., Benedetto, V., . . . Chatterjee, K. (2019). Diagnostic workup in cases of cryptogenic stroke: a systematic review and comparison of international clinical practice guidelines. In INTERNATIONAL JOURNAL OF STROKE Vol. 14 (pp. 49). Retrieved from https://www.webofscience.com/
Pritchett, R. V., Bem, D., Turner, G. M., Thomas, G. N., Clarke, J. L., Fellows, R., . . . Jolly, K. (2019). Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review. THROMBOSIS AND HAEMOSTASIS, 119(2), 294-307. doi:10.1055/s-0038-1676835DOI: 10.1055/s-0038-1676835
Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management (Journal article)
Ritchie, L. A., Penson, P. E., & Lane, D. A. (2019). Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management. THROMBOSIS AND HAEMOSTASIS, 119(10), 1550-1552. doi:10.1055/s-0039-1696982DOI: 10.1055/s-0039-1696982
2018
Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report (Journal article)
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., . . . Moores, L. (2018). Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report. Chest, 154(5), 1121-1201. doi:10.1016/j.chest.2018.07.040DOI: 10.1016/j.chest.2018.07.040
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2018). Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. AMERICAN JOURNAL OF MEDICINE, 131(11), 1359-+. doi:10.1016/j.amjmed.2018.06.012DOI: 10.1016/j.amjmed.2018.06.012
Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis (Journal article)
Reavell, J., Hopkinson, M., Clarkesmith, D., & Lane, D. A. (2018). Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. Psychosomatic Medicine, 80(8), 742-753. doi:10.1097/psy.0000000000000626DOI: 10.1097/psy.0000000000000626
European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (Journal article)
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Shantsila, A. (2018). European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. EUROPACE, 20(9), 1399-+. doi:10.1093/europace/euy046DOI: 10.1093/europace/euy046
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., Lane, D. A., . . . Lip, G. Y. H. (2018). Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 55, 28-34. doi:10.1016/j.ejim.2018.05.016DOI: 10.1016/j.ejim.2018.05.016
113Mean blood pressures and visit to visit blood pressure variation as predictors of clinical outcomes in malignant hypertension: the west Birmingham malignant hypertension project (Journal article)
Ayetey, H., Shantsila, A., Li, Y. G., Lane, D. A., & Lip, G. Y. H. (2018). 113Mean blood pressures and visit to visit blood pressure variation as predictors of clinical outcomes in malignant hypertension: the west Birmingham malignant hypertension project. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy564.113DOI: 10.1093/eurheartj/ehy564.113
P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (Journal article)
Proietti, M., Laroche, C., Popescu, M. I., Tello-Montoliu, A., Garcia-Bolao, I., Lane, D. A., . . . Boriani, G. (2018). P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy563.p3446DOI: 10.1093/eurheartj/ehy563.p3446
P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (Journal article)
Penson, P. E., Awad, K., Lane, D., Banach, M., & Lip, G. Y. H. (2018). P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy563.p3836DOI: 10.1093/eurheartj/ehy563.p3836
The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (Conference Paper)
Penson, P. E., Awad, K., Lane, D., Banach, M., & Lip, G. Y. H. (2018). The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 817). Retrieved from https://www.webofscience.com/
Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence (Journal article)
Szekely, O., Lane, D. A., & Lip, G. Y. H. (2018). Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence. EUROPEAN HEART JOURNAL, 39(25), 2365-2367. doi:10.1093/eurheartj/ehy308DOI: 10.1093/eurheartj/ehy308
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018). Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.. TH open : companion journal to thrombosis and haemostasis, 2(3), e233-e241. doi:10.1055/s-0038-1666803DOI: 10.1055/s-0038-1666803
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue? (Journal article)
Proietti, M., & Lane, D. A. (2018). Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?. THROMBOSIS AND HAEMOSTASIS, 118(7), 1123-1126. doi:10.1055/s-0038-1661370DOI: 10.1055/s-0038-1661370
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018). Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis. CLINICAL CARDIOLOGY, 41(6), 855-861. doi:10.1002/clc.22971DOI: 10.1002/clc.22971
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. HEART RHYTHM, 15(6), E37-E60. doi:10.1016/j.hrthm.2018.03.005DOI: 10.1016/j.hrthm.2018.03.005
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (Journal article)
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2018). Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. EUROPACE, 20(5), 747-757. doi:10.1093/europace/eux301DOI: 10.1093/europace/eux301
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Blomstrom-Lundqvist, C. (2018). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPEAN HEART JOURNAL, 39(16), 1442-1445. doi:10.1093/eurheartj/ehw455DOI: 10.1093/eurheartj/ehw455
Lip, G. Y. H., Lane, D. A., & Potpara, T. S. (2018). Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 39(16), 1404-1406. doi:10.1093/eurheartj/ehx807DOI: 10.1093/eurheartj/ehx807
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (Journal article)
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?. JOURNAL OF ARRHYTHMIA, 34(2), 99-123. doi:10.1002/joa3.12050DOI: 10.1002/joa3.12050
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. HEART RHYTHM, 15(4), 615-623. doi:10.1016/j.hrthm.2017.11.026DOI: 10.1016/j.hrthm.2017.11.026
Epidemiology of atrial fibrillation (Journal article)
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Epidemiology of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13070DOI: 10.1111/ijcp.13070
Individual depressive symptoms and all-cause mortality In 6673 patients with myocardial infarction: Heterogeneity across age and sex subgroups (Journal article)
Azevedo, R. D. M., Roest, A. M., Carney, R. M., Freedland, K. E., Lane, D. A., Parakh, K., . . . Denollet, J. (2018). Individual depressive symptoms and all-cause mortality In 6673 patients with myocardial infarction: Heterogeneity across age and sex subgroups. JOURNAL OF AFFECTIVE DISORDERS, 228, 178-185. doi:10.1016/j.jad.2017.11.025DOI: 10.1016/j.jad.2017.11.025
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (Journal article)
Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., . . . Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. EUROPACE, 20(3), 395-407. doi:10.1093/europace/eux318DOI: 10.1093/europace/eux318
Qualitative exploration of the effect of a television soap opera storyline on women with experience of postpartum psychosis (Journal article)
Roberts, L., Bernsford, G., Heron, J., Jones, L., Jones, I., Dolman, C., & Lane, D. A. (2018). Qualitative exploration of the effect of a television soap opera storyline on women with experience of postpartum psychosis. BJPSYCH OPEN, 4(2), 75-82. doi:10.1192/bjo.2018.9DOI: 10.1192/bjo.2018.9
Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey (Journal article)
Boveda, S., Lenarczyk, R., Haugaa, K. H., Iliodromitis, K., Finlay, M., Lane, D., . . . Dagres, N. (2018). Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey. EUROPACE, 20(3), 555-559. doi:10.1093/europace/eux381DOI: 10.1093/europace/eux381
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial (Journal article)
Proietti, M., Hijazi, Z., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., . . . Investigators, R. E. -L. Y. (2018). Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial. Journal of Internal Medicine, 283(3), 282-292. doi:10.1111/joim.12702DOI: 10.1111/joim.12702
Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study (Conference Paper)
Khalid, U., Egeberg, A., Ahlehoff, O., Lane, D., Gislason, G. H., Lip, G. Y. H., & Hansen, P. R. (2018). Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 7. doi:10.1161/JAHA.117.007227DOI: 10.1161/JAHA.117.007227
Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (Conference Paper)
Proietti, M., Laroche, C., Popescu, M. I., Tello-Montoliu, A., Garcia-Bolao, I., Lane, D. A., . . . Boriani, G. (2018). Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 694-695). Retrieved from https://www.webofscience.com/
2017
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial (Journal article)
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017). Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. AMERICAN JOURNAL OF MEDICINE, 130(12), 1388-1396.e6. doi:10.1016/j.amjmed.2017.07.003DOI: 10.1016/j.amjmed.2017.07.003
Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). (Journal article)
Sarkozy, A., De Potter, T., Heidbuchel, H., Ernst, S., Kosiuk, J., Vano, E., . . . ESC Scientific Document Group. (2017). Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(12), 1909-1922. doi:10.1093/europace/eux252DOI: 10.1093/europace/eux252
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Scott-Millar, R. (2017). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(11), 1757-+. doi:10.1093/europace/eux240DOI: 10.1093/europace/eux240
Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis (Journal article)
Jeyanantham, K., Kotecha, D., Thanki, D., Dekker, R., & Lane, D. A. (2017). Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. HEART FAILURE REVIEWS, 22(6), 731-741. doi:10.1007/s10741-017-9640-5DOI: 10.1007/s10741-017-9640-5
Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation (Journal article)
Lip, G. Y. H., Lane, D. A., & Sarwar, S. (2017). Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 38(40), 2980-2982. doi:10.1093/eurheartj/ehx554DOI: 10.1093/eurheartj/ehx554
Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism (Journal article)
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2017). Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. AMERICAN JOURNAL OF CARDIOLOGY, 120(7), 1139-1145. doi:10.1016/j.amjcard.2017.06.058DOI: 10.1016/j.amjcard.2017.06.058
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., . . . Sapp, J. L. (2017). Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(10), 1589-1623. doi:10.1093/europace/eux177DOI: 10.1093/europace/eux177
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Gorenek, B., Bax, J., Boriani, G., Chen, S. -A., Dagres, N., Glotzer, T. V., . . . Savelieva, I. (2017). Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(9), 1556-1578. doi:10.1093/europace/eux163DOI: 10.1093/europace/eux163
5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (Journal article)
Proietti, M., Bouvet, P. E., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., . . . Lip, G. Y. H. (2017). 5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. European Heart Journal, 38(suppl_1). doi:10.1093/eurheartj/ehx493.5769DOI: 10.1093/eurheartj/ehx493.5769
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry. MAYO CLINIC PROCEEDINGS, 92(8), 1203-1213. doi:10.1016/j.mayocp.2017.05.023DOI: 10.1016/j.mayocp.2017.05.023
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry (Journal article)
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry. STROKE, 48(8), 2198-2205. doi:10.1161/STROKEAHA.116.016146DOI: 10.1161/STROKEAHA.116.016146
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. (Journal article)
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H. -C., Hacke, W., . . . ESC Scientific Document Group. (2017). Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.. European heart journal, 38(27), 2137-2149. doi:10.1093/eurheartj/ehw058DOI: 10.1093/eurheartj/ehw058
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study (Journal article)
Clarkesmith, D. E., Lip, G. Y. H., & Lane, D. A. (2017). Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. THROMBOSIS RESEARCH, 153, 19-27. doi:10.1016/j.thromres.2017.03.002DOI: 10.1016/j.thromres.2017.03.002
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care (Journal article)
Lane, D. A., Skjoth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017). Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. Journal of the American Heart Association, 6(5). doi:10.1161/JAHA.116.005155DOI: 10.1161/JAHA.116.005155
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. (Journal article)
Clarkesmith, D. E., Pattison, H. M., Khaing, P. H., & Lane, D. A. (2017). Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.. The Cochrane database of systematic reviews, (4), 1-68. doi:10.1002/14651858.CD008600.pub3DOI: 10.1002/14651858.CD008600.pub3
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2017). Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBIOMEDICINE, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022DOI: 10.1016/j.ebiom.2017.03.022
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (Journal article)
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2017). Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. EUROPACE, 19(4), 535-543. doi:10.1093/europace/euw150DOI: 10.1093/europace/euw150
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 (Journal article)
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. EUROPEAN HEART JOURNAL, 38(12), 852-859B. doi:10.1093/eurheartj/ehv643DOI: 10.1093/eurheartj/ehv643
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2 (Journal article)
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. EUROPEAN HEART JOURNAL, 38(12), 860-868. doi:10.1093/eurheartj/ehw069DOI: 10.1093/eurheartj/ehw069
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Rickard, J. (2017). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(3), 465-511. doi:10.1093/europace/euw301DOI: 10.1093/europace/euw301
The wearable cardioverter-defibrillator: current technology and evolving indications. (Journal article)
Reek, S., Burri, H., Roberts, P. R., Perings, C., Epstein, A. E., Klein, H. U., . . . Savelieva, I. (2017). The wearable cardioverter-defibrillator: current technology and evolving indications.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(3), 335-345. doi:10.1093/europace/euw180DOI: 10.1093/europace/euw180
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 19(2), 190-225. doi:10.1093/europace/euw242DOI: 10.1093/europace/euw242
Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants (Journal article)
Raparelli, V., Proietti, M., Cangemi, R., Lip, G. Y. H., Lane, D. A., & Basili, S. (2017). Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants. THROMBOSIS AND HAEMOSTASIS, 117(2), 209-218. doi:10.1160/TH16-10-0757DOI: 10.1160/TH16-10-0757
Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project (Conference Paper)
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2017). Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770-771). Retrieved from https://www.webofscience.com/
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Rocca, B. (2017). Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). THROMBOSIS AND HAEMOSTASIS, 117(12), 2215-2236. doi:10.1160/TH-17-10-0709DOI: 10.1160/TH-17-10-0709
Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (Conference Paper)
Proietti, M., Bouvet, P. E., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220-1221). Retrieved from https://www.webofscience.com/
Effect of Educational Level on Atrial Fibrillation Patients' Knowledge and Perceptions About Oral Anticoagulation Therapy: Results From an International Study (Conference Paper)
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. (2017). Effect of Educational Level on Atrial Fibrillation Patients' Knowledge and Perceptions About Oral Anticoagulation Therapy: Results From an International Study. In STROKE Vol. 48. Retrieved from https://www.webofscience.com/
Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation (Conference Paper)
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J., Maggioni, A., Lane, D. A., . . . Lip, G. Y. (2017). Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 4-40. doi:10.1177/2047487316676037DOI: 10.1177/2047487316676037
Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)
Proietti, M., Lane, D. A., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from https://www.webofscience.com/
Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey (Conference Paper)
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2017). Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 777). Retrieved from https://www.webofscience.com/
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPACE, 19(1), 139-163. doi:10.1093/europace/euw243DOI: 10.1093/europace/euw243
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 41-69. doi:10.1177/2047487316676042DOI: 10.1177/2047487316676042
2016
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Jais, P., Hindricks, G., Josephson, M. E., . . . Lundqvist, C. B. (2016). Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 5(3), 210-224. doi:10.15420/aer.2016.5.3.GL1DOI: 10.15420/aer.2016.5.3.GL1
Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom (Journal article)
Senoo, K., An, Y., Ogawa, H., Lane, D. A., Wolff, A., Shantsila, E., . . . Lip, G. Y. H. (2016). Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom. HEART, 102(23), 1878-1882. doi:10.1136/heartjnl-2016-309741DOI: 10.1136/heartjnl-2016-309741
International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives (Journal article)
Hsu, J. C., Akao, M., Abe, M., Anderson, K. L., Avezum, A., Glusenkamp, N., . . . Maddox, T. M. (2016). International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(11). doi:10.1161/JAHA.116.004037DOI: 10.1161/JAHA.116.004037
Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review (Journal article)
Moffitt, P., Lane, D. A., Park, H., O'Connell, J., & Quinn, T. J. (2016). Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review. AGE AND AGEING, 45(6), 767-775. doi:10.1093/ageing/afw104DOI: 10.1093/ageing/afw104
Adolescents' and Young Adults' Lived Experiences Following Venous Thromboembolism "<i>It will always lie in wait</i>" (Journal article)
Hojen, A. A., Dreyer, P. S., Lane, D. A., Larsen, T. B., & Sorensen, E. E. (2016). Adolescents' and Young Adults' Lived Experiences Following Venous Thromboembolism "<i>It will always lie in wait</i>". NURSING RESEARCH, 65(6), 455-464. doi:10.1097/NNR.0000000000000183DOI: 10.1097/NNR.0000000000000183
Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement Properties (Journal article)
Kotecha, D., Ahmed, A., Calvert, M., Lencioni, M., Terwee, C. B., & Lane, D. A. (2016). Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement Properties. PloS one, 11(11), 13 pages. doi:10.1371/journal.pone.0165790DOI: 10.1371/journal.pone.0165790
Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores (Journal article)
Lip, G. Y. H., & Lane, D. A. (2016). Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(9), 1711-1714. doi:10.1111/jth.13386DOI: 10.1111/jth.13386
Stroke prevention in atrial fibrillation: can we do better? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: can we do better?. NATURE REVIEWS CARDIOLOGY, 13(9), 511-512. doi:10.1038/nrcardio.2016.117DOI: 10.1038/nrcardio.2016.117
Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials (Journal article)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 216, 168-172. doi:10.1016/j.ijcard.2016.04.131DOI: 10.1016/j.ijcard.2016.04.131
Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease (Journal article)
Potpara, T. S., Jokic, V., Dagres, N., Larsen, T. B., Lane, D. A., Hindricks, G., & Lip, G. Y. H. (2016). Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. CURRENT MEDICINAL CHEMISTRY, 23(19), 2055-2069. doi:10.2174/0929867323666160210130109DOI: 10.2174/0929867323666160210130109
Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials) (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials). In AMERICAN JOURNAL OF CARDIOLOGY Vol. 118 (pp. 72-78). doi:10.1016/j.amjcard.2016.04.013DOI: 10.1016/j.amjcard.2016.04.013
A Bifactor Model of the Beck Depression Inventory and Its Association With Medical Prognosis After Myocardial Infarction (Journal article)
Azevedo, R. D. M., Roest, A. M., Carney, R. M., Denollet, J., Freedland, K. E., Grace, S. L., . . . de Jonge, P. (2016). A Bifactor Model of the Beck Depression Inventory and Its Association With Medical Prognosis After Myocardial Infarction. HEALTH PSYCHOLOGY, 35(6), 614-624. doi:10.1037/hea0000316DOI: 10.1037/hea0000316
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials. EBIOMEDICINE, 8, 309-316. doi:10.1016/j.ebiom.2016.04.013DOI: 10.1016/j.ebiom.2016.04.013
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin (Journal article)
Senoo, K., Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. AMERICAN JOURNAL OF MEDICINE, 129(6), 600-607. doi:10.1016/j.amjmed.2015.10.001DOI: 10.1016/j.amjmed.2015.10.001
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores (Journal article)
Proietti, M., Senoo, K., Lane, D. A., & Lip, G. Y. H. (2016). Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores. SCIENTIFIC REPORTS, 6. doi:10.1038/srep24376DOI: 10.1038/srep24376
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (Conference Paper)
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. (2016). PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 688). doi:10.1016/S0735-1097(16)30689-1DOI: 10.1016/S0735-1097(16)30689-1
Patients’ and physicians’ experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design (Journal article)
Borg Xuereb, C., Shaw, R. L., & Lane, D. A. (2016). Patients’ and physicians’ experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design. Psychology & Health, 31(4), 436-455. doi:10.1080/08870446.2015.1116534DOI: 10.1080/08870446.2015.1116534
Atrial fibrillation (Journal article)
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., . . . Lane, D. A. (2016). Atrial fibrillation. NATURE REVIEWS DISEASE PRIMERS, 2. doi:10.1038/nrdp.2016.16DOI: 10.1038/nrdp.2016.16
The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation (Journal article)
Lip, G. Y. H., & Lane, D. A. (2016). The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation. ANNALS OF INTERNAL MEDICINE, 164(2), JC11. doi:10.7326/ACPJC-2016-164-2-011DOI: 10.7326/ACPJC-2016-164-2-011
Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes (Journal article)
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016). Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 660-666. doi:10.1016/j.ijcard.2015.10.220DOI: 10.1016/j.ijcard.2015.10.220
Developing a Complex Educational-Behavioural Intervention: The TREAT Intervention for Patients with Atrial Fibrillation (Journal article)
Clarkesmith, D. E., Pattison, H. M., Xuereb, C. B., & Lane, D. A. (2016). Developing a Complex Educational-Behavioural Intervention: The TREAT Intervention for Patients with Atrial Fibrillation. HEALTHCARE, 4(1). doi:10.3390/healthcare4010010DOI: 10.3390/healthcare4010010
Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1345). Retrieved from https://www.webofscience.com/
Comparison of Contemporary Bleeding Risk Scores in Patients With Non-Valvular Atrial Fibrillation Treated With Dabigatran or Warfarin: Insights From the RE-LY Trial (Conference Paper)
Proietti, M., Hijazi, Z., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., . . . Wallentin, L. (2016). Comparison of Contemporary Bleeding Risk Scores in Patients With Non-Valvular Atrial Fibrillation Treated With Dabigatran or Warfarin: Insights From the RE-LY Trial. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment (Conference Paper)
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2016). Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 506). Retrieved from https://www.webofscience.com/
Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1137-1138). Retrieved from https://www.webofscience.com/
Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Quality of life in atrial fibrillation: a systematic review of AF-specific questionnaires (Conference Paper)
Ahmed, A., Lane, D. A., Calvert, M., Terwee, C. B., Lencioni, M., & Kotecha, D. (2016). Quality of life in atrial fibrillation: a systematic review of AF-specific questionnaires. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 498). Retrieved from https://www.webofscience.com/
Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 828). Retrieved from https://www.webofscience.com/
2015
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference (Journal article)
Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., . . . Camm, A. J. (2016). A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. EUROPACE, 18(1), 37-50. doi:10.1093/europace/euv304DOI: 10.1093/europace/euv304
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)
Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2016). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPACE, 18(1), 12-36. doi:10.1093/europace/euv191DOI: 10.1093/europace/euv191
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study (Journal article)
Blann, A. D., Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2015). Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 693-698. doi:10.1016/j.ijcard.2015.08.074DOI: 10.1016/j.ijcard.2015.08.074
Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project (Journal article)
Xiong, Q., Shantsila, A., Lane, D. A., Zhou, Q., Liu, Y., Shen, Y., . . . Lip, G. Y. H. (2015). Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 195-199. doi:10.1016/j.ijcard.2015.08.076DOI: 10.1016/j.ijcard.2015.08.076
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. EUROPEAN HEART JOURNAL, 36(46), 3265-3267. doi:10.1093/eurheartj/ehv415DOI: 10.1093/eurheartj/ehv415
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) (Journal article)
Lane, D. A., Aguinaga, L., Blomstrom-Lundqvist, C., Boriani, G., Dan, G. -A., Hills, M. T., . . . Potpara, T. S. (2015). Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). EUROPACE, 17(12), 1747-1769. doi:10.1093/europace/euv233DOI: 10.1093/europace/euv233
Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(21), 2282-2284. doi:10.1016/j.jacc.2015.07.086DOI: 10.1016/j.jacc.2015.07.086
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).. European heart journal, 36(41), 2793-2867. doi:10.1093/eurheartj/ehv316DOI: 10.1093/eurheartj/ehv316
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials (Journal article)
Xiong, Q., Lau, Y. C., Senoo, K., Lane, D. A., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. EUROPEAN JOURNAL OF HEART FAILURE, 17(11), 1192-1200. doi:10.1002/ejhf.343DOI: 10.1002/ejhf.343
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic (Journal article)
Lee, S. I., Sayers, M., Lip, G. Y. H., & Lane, D. A. (2015). Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1341-1348. doi:10.1111/ijcp.12712DOI: 10.1111/ijcp.12712
Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation (Journal article)
Madzak, A., Larsen, T. B., Lane, D. A., Lip, G. Y. H., & Nielsen, P. B. (2015). Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 13(10), 1155-1163. doi:10.1586/14779072.2015.1086643DOI: 10.1586/14779072.2015.1086643
Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry (Conference Paper)
Xiong, Q., Shantsila, A., Zhou, Q., Liu, Y., Shen, Y., Lane, D., . . . Lip, G. Y. H. (2015). Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C184). doi:10.1016/j.jacc.2015.06.703DOI: 10.1016/j.jacc.2015.06.703
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) (Journal article)
Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). EUROPEAN HEART JOURNAL, 36(41), 2793-+. doi:10.1093/eurheartj/ehv316DOI: 10.1093/eurheartj/ehv316
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial (Journal article)
Senoo, K., Lip, G. Y. H., Lane, D. A., Bueller, H. R., & Kotecha, D. (2015). Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial. STROKE, 46(9), 2523-2528. doi:10.1161/STROKEAHA.115.009487DOI: 10.1161/STROKEAHA.115.009487
Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation (Journal article)
Melgaard, L., Gorst-Rasmussen, A., Lane, D. A., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(10), 1030-1038. doi:10.1001/jama.2015.10725DOI: 10.1001/jama.2015.10725
Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(9), 949-950. doi:10.1001/jama.2015.8995DOI: 10.1001/jama.2015.8995
Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice (Journal article)
Wolff, A., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2015). Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AGE AND AGEING, 44(5), 874-878. doi:10.1093/ageing/afv071DOI: 10.1093/ageing/afv071
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data (Journal article)
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Kotecha, D. (2015). Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ: British Medical Journal, 351. doi:10.1136/bmj.h4451DOI: 10.1136/bmj.h4451
Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)) (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)). JAMA - Journal of the American Medical Association, 314(8), 837.
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)
Boriani, G., Savelieva, I., Dan, G. -A., Deharo, J. C., Ferro, C., Israel, C. W., . . . Lip, G. Y. H. (2015). Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace, 17(8), 1169-1196. doi:10.1093/europace/euv202DOI: 10.1093/europace/euv202
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study (Journal article)
Overvad, T. F., Skjoth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study. STROKE, 46(8), 2168-2174. doi:10.1161/STROKEAHA.115.009371DOI: 10.1161/STROKEAHA.115.009371
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool (Journal article)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(8), 840-845. doi:10.1111/ijcp.12625DOI: 10.1111/ijcp.12625
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice (Journal article)
Boriani, G., Lane, D. A., Windecker, S., Huber, K., Kirchhof, P., & Lip, G. Y. H. (2015). Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. EUROPACE, 17(9), 1319-1322. doi:10.1093/europace/euu303DOI: 10.1093/europace/euu303
Atrial fibrillation (chronic). (Journal article)
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2015). Atrial fibrillation (chronic).. BMJ clinical evidence, 2015, 0217.
Stroke Prevention in Atrial Fibrillation: A Systematic Review (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review. JAMA: Journal of the American Medical Association, 313(19), 1950-1962. doi:10.1001/jama.2015.4369DOI: 10.1001/jama.2015.4369
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis (Journal article)
Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(5), 418-429. doi:10.1007/s00392-014-0797-9DOI: 10.1007/s00392-014-0797-9
Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation (Journal article)
Lane, D. A., & Wood, K. (2015). Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation. CIRCULATION, 131(16), E412-E415. doi:10.1161/CIRCULATIONAHA.114.012808DOI: 10.1161/CIRCULATIONAHA.114.012808
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study (Journal article)
Gorst-Rasmussen, A., Skjoth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015). Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(4), 495-504. doi:10.1111/jth.12845DOI: 10.1111/jth.12845
Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes (Journal article)
Potpara, T. S., Lane, D. A., & Lip, G. Y. H. (2015). Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. EUROPACE, 17(4), 507-508. doi:10.1093/europace/euv041DOI: 10.1093/europace/euv041
Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study (Journal article)
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study. THROMBOSIS RESEARCH, 135(4), 643-647. doi:10.1016/j.thromres.2015.01.024DOI: 10.1016/j.thromres.2015.01.024
Optimising stroke prevention in patients with atrial fibrillation (Journal article)
Lane, D. A., Wolff, A., Shantsila, E., & Lip, G. Y. H. (2015). Optimising stroke prevention in patients with atrial fibrillation. BRITISH JOURNAL OF GENERAL PRACTICE, 65(632), 117. doi:10.3399/bjgp15X683905DOI: 10.3399/bjgp15X683905
Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis (Journal article)
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2015). Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 181, 247-254. doi:10.1016/j.ijcard.2014.11.196DOI: 10.1016/j.ijcard.2014.11.196
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis - (Journal article)
Senoo, K., Lau, Y. C., Dzeshka, M., Lane, D., Okumura, K., & Lip, G. Y. H. (2015). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -. CIRCULATION JOURNAL, 79(2), 339-345. doi:10.1253/circj.CJ-14-1042DOI: 10.1253/circj.CJ-14-1042
Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study (Conference Paper)
Overvad, T. F., Skjoeth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 910). Retrieved from https://www.webofscience.com/
Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases (Conference Paper)
Hojen, A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases. In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 14 (pp. S7). Retrieved from https://www.webofscience.com/
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort (Journal article)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), E16-E23. doi:10.3399/bjgp15X683113DOI: 10.3399/bjgp15X683113
Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study (Conference Paper)
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., . . . Larsen, T. B. (2015). Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 283). Retrieved from https://www.webofscience.com/
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement (Journal article)
Capodanno, D., Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Boriani, G., . . . Byrne, R. A. (2015). Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EUROINTERVENTION, 10(9), 1015-1021. doi:10.4244/EIJV10I9A174DOI: 10.4244/EIJV10I9A174
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Van Veldhuisen, D. J. (2015). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].. Kardiologia polska, 73(10), 795-900. doi:10.5603/kp.2015.0190DOI: 10.5603/kp.2015.0190
2014
Best Practice for Atrial Fibrillation Patient Education (Journal article)
Lane, D. A., Barker, R. V., & Lip, G. Y. H. (2015). Best Practice for Atrial Fibrillation Patient Education. CURRENT PHARMACEUTICAL DESIGN, 21(5), 533-543. Retrieved from https://www.webofscience.com/
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study (Journal article)
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Lane, D. A., & Lip, G. Y. H. (2014). Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 127(12), 1172-1178. doi:10.1016/j.amjmed.2014.07.023DOI: 10.1016/j.amjmed.2014.07.023
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis (Journal article)
Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014). Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107(12), 955-967. doi:10.1093/qjmed/hcu054DOI: 10.1093/qjmed/hcu054
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) (Journal article)
Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Marin, F., Ten Berg, J. M., . . . Lane, D. (2014). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). EUROPEAN HEART JOURNAL, 35(45), 3155-3179. doi:10.1093/eurheartj/ehu298DOI: 10.1093/eurheartj/ehu298
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (Journal article)
Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A. J., Hindricks, G., Huber, K., . . . Savelieva, I. (2014). Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 16(11), 1655-1673. doi:10.1093/europace/euu208DOI: 10.1093/europace/euu208
The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study (Journal article)
Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Lane, D. A., Rasmussen, L. H., & Larsen, T. B. (2014). The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study. CHEST, 146(5), 1337-1346. doi:10.1378/chest.14-0533DOI: 10.1378/chest.14-0533
Pocket Ready to Eat at Home in Primary Care Reply (Journal article)
Prasad, V., Kim, J., & Rho, J. (2014). Pocket Ready to Eat at Home in Primary Care Reply. AMERICAN JOURNAL OF MEDICINE, 127(3), E21. doi:10.1016/j.amjmed.2013.11.005DOI: 10.1016/j.amjmed.2013.11.005
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More) (Journal article)
Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More). CLINICAL CARDIOLOGY, 37(10), 634-644. doi:10.1002/clc.22294DOI: 10.1002/clc.22294
Stroke and Bleeding Risk in Atrial Fibrillation (Journal article)
Senoo, K., Lane, D., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation. KOREAN CIRCULATION JOURNAL, 44(5), 281-290. doi:10.4070/kcj.2014.44.5.281DOI: 10.4070/kcj.2014.44.5.281
The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review (Journal article)
Agarwal, M., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2014). The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review. CLINICAL THERAPEUTICS, 36(9), 1135-1144. doi:10.1016/j.clinthera.2014.07.015DOI: 10.1016/j.clinthera.2014.07.015
Diving to the foot of an iceberg: The SEARCH for undiagnosed atrial fibrillation (Journal article)
Potpara, T. S., & Lane, D. A. (2014). Diving to the foot of an iceberg: The SEARCH for undiagnosed atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 112(1), 1-3. doi:10.1160/TH14-05-0437DOI: 10.1160/TH14-05-0437
Atrial Fibrillation and Heart Failure: A Bad Combination (Journal article)
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation and Heart Failure: A Bad Combination. AMERICAN JOURNAL OF CARDIOLOGY, 113(7), 1196-1197. doi:10.1016/j.amjcard.2014.01.002DOI: 10.1016/j.amjcard.2014.01.002
Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2014). Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. THROMBOSIS AND HAEMOSTASIS, 111(3), 381-383. doi:10.1160/TH14-01-0063DOI: 10.1160/TH14-01-0063
The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation (Journal article)
Albertsen, I. E., Rasmussen, L. H., Lane, D. A., Overvad, T. F., Skjoth, F., Overvad, K., . . . Larsen, T. B. (2014). The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation. CHEST, 145(3), 559-566. doi:10.1378/chest.13-1740DOI: 10.1378/chest.13-1740
An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis (Journal article)
Munyombwe, T., Hoefer, S., Fitzsimons, D., Thompson, D. R., Lane, D., Smith, K., & Astin, F. (2014). An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis. QUALITY OF LIFE RESEARCH, 23(6), 1753-1765. doi:10.1007/s11136-013-0617-0DOI: 10.1007/s11136-013-0617-0
Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool (Conference Paper)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014). Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1104). Retrieved from https://www.webofscience.com/
Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking (Journal article)
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking. STROKE, 45(11), 3184-3185. doi:10.1161/STROKEAHA.114.006862DOI: 10.1161/STROKEAHA.114.006862
Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction (Conference Paper)
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2014). Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1029). Retrieved from https://www.webofscience.com/
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation (Journal article)
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2014). Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 112(4), 789-795. doi:10.1160/TH14-06-0545DOI: 10.1160/TH14-06-0545
Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction (Journal article)
Lip, G. Y. H., & Lane, D. A. (2014). Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction. CIRCULATION JOURNAL, 78(8), 1843-1845. doi:10.1253/circj.CJ-14-0584DOI: 10.1253/circj.CJ-14-0584
Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin (Journal article)
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Rosenzweig, M., Lane, D. A., & Lip, G. Y. H. (2014). Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin. AMERICAN JOURNAL OF MEDICINE, 127(4), 329-+. doi:10.1016/j.amjmed.2013.12.005DOI: 10.1016/j.amjmed.2013.12.005
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation (Journal article)
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014). Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CURRENT PROBLEMS IN CARDIOLOGY, 39(9), 319-344. doi:10.1016/j.cpcardiol.2014.07.001DOI: 10.1016/j.cpcardiol.2014.07.001
The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences (Conference Paper)
Xuereb, C. B., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2014). The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 12 (pp. 11). Retrieved from https://www.webofscience.com/
Use of the HAS-BLED bleeding score in real-life settings (Journal article)
Lane, D. A., & Lip, G. Y. H. (2014). Use of the HAS-BLED bleeding score in real-life settings. THROMBOSIS RESEARCH, 134(1), 202. doi:10.1016/j.thromres.2014.03.027DOI: 10.1016/j.thromres.2014.03.027
2013
Treatment of hypertension in peripheral arterial disease (Journal article)
Lane, D. A., & Lip, G. Y. H. (2013). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD003075.pub3DOI: 10.1002/14651858.CD003075.pub3
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial (Journal article)
Apostolakis, S., Guo, Y., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. EUROPEAN HEART JOURNAL, 34(46), 3572-3579. doi:10.1093/eurheartj/eht328DOI: 10.1093/eurheartj/eht328
Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial (Journal article)
Apostolakis, S., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial. THROMBOSIS AND HAEMOSTASIS, 110(5), 1074-1079. doi:10.1160/TH13-07-0552DOI: 10.1160/TH13-07-0552
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference (Conference Paper)
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., . . . Camm, A. J. (2013). Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 15 (pp. 1540-1556). doi:10.1093/europace/eut232DOI: 10.1093/europace/eut232
Psychological interventions for depression in adolescent and adult congenital heart disease (Journal article)
Lane, D. A., Millane, T. A., & Lip, G. Y. H. (2013). Psychological interventions for depression in adolescent and adult congenital heart disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD004372.pub2DOI: 10.1002/14651858.CD004372.pub2
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry (Journal article)
Apostolakis, S., Zubaid, M., Rashed, W. A., Alsheikh-Ali, A. A., Almahmeed, W., Shehab, A., . . . Lip, G. Y. H. (2013). Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(2), 1644-1646. doi:10.1016/j.ijcard.2013.02.003DOI: 10.1016/j.ijcard.2013.02.003
Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2013). Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(6), 2682-2687. doi:10.1016/j.ijcard.2012.06.118DOI: 10.1016/j.ijcard.2012.06.118
Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial (Journal article)
Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013). Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial. PLOS ONE, 8(9). doi:10.1371/journal.pone.0074037DOI: 10.1371/journal.pone.0074037
Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review (Journal article)
Udompanich, S., Lip, G. Y. H., Apostolakis, S., & Lane, D. A. (2013). Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 106(9), 795-802. doi:10.1093/qjmed/hct129DOI: 10.1093/qjmed/hct129
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation (Journal article)
Krishnamoorthy, S., Khoo, C. W., Lim, H. S., Lane, D. A., Pignatelli, P., Basili, S., . . . Lip, G. Y. H. (2013). Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(10), 1032-1038. doi:10.1111/eci.12140DOI: 10.1111/eci.12140
Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis (Journal article)
Meijer, A., Conradi, H. J., Bos, E. H., Anselmino, M., Carney, R. M., Denollet, J., . . . de Jonge, P. (2013). Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. BRITISH JOURNAL OF PSYCHIATRY, 203(2), 90-102. doi:10.1192/bjp.bp.112.111195DOI: 10.1192/bjp.bp.112.111195
Alcohol intake and prognosis of atrial fibrillation (Journal article)
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2013). Alcohol intake and prognosis of atrial fibrillation. HEART, 99(15), 1093-1099. doi:10.1136/heartjnl-2013-304036DOI: 10.1136/heartjnl-2013-304036
Description of the underlying health problem (Journal article)
Lane, D. A., Raichand, S., Moore, D., Connock, M., Fry-Smith, A., & Fitzmaurice, D. A. (2013). Description of the underlying health problem. HEALTH TECHNOLOGY ASSESSMENT, 17(30), 1-+. doi:10.3310/hta17300DOI: 10.3310/hta17300
Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range (Journal article)
Gallego, P., Antonio Vilchez, J., & Lane, D. A. (2013). Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range. CIRCULATION, 127(22), 2163-2165. doi:10.1161/CIRCULATIONAHA.113.003132DOI: 10.1161/CIRCULATIONAHA.113.003132
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation (Journal article)
Clarkesmith, D. E., Pattison, H. M., & Lane, D. A. (2013). Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD008600.pub2DOI: 10.1002/14651858.CD008600.pub2
Bleeding risk during oral anticoagulation therapy for atrial fibrillation (Journal article)
Gallego, P., Lip, G. Y. H., & Lane, D. A. (2013). Bleeding risk during oral anticoagulation therapy for atrial fibrillation. EUROPACE, 15(6), 773-774. doi:10.1093/europace/eut061DOI: 10.1093/europace/eut061
Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project (Journal article)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2013). Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project. HYPERTENSION RESEARCH, 36(6), 546-549. doi:10.1038/hr.2012.222DOI: 10.1038/hr.2012.222
Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly- (Journal article)
Lip, G. Y. H., & Lane, D. A. (2013). Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly-. CIRCULATION JOURNAL, 77(6), 1380-1388. doi:10.1253/circj.CJ-13-0465DOI: 10.1253/circj.CJ-13-0465
ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2013). ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients?. NATURE REVIEWS CARDIOLOGY, 10(5), 241-242. doi:10.1038/nrcardio.2013.47DOI: 10.1038/nrcardio.2013.47
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review (Journal article)
Anandasundaram, B., Lane, D. A., Apostolakis, S., & Lip, G. Y. H. (2013). The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 11(5), 975-987. doi:10.1111/jth.12177DOI: 10.1111/jth.12177
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey (Journal article)
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2013). Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey. THROMBOSIS AND HAEMOSTASIS, 109(2), 328-336. doi:10.1160/TH12-08-0539DOI: 10.1160/TH12-08-0539
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications (Journal article)
Karthikeyan, V. J., Lane, D. A., Beevers, D. G., Lip, G. Y. H., & Blann, A. D. (2013). Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. JOURNAL OF HUMAN HYPERTENSION, 27(2), 72-78. doi:10.1038/jhh.2012.8DOI: 10.1038/jhh.2012.8
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients (Journal article)
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2013). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(3), 386-387. doi:10.1016/j.jacc.2012.10.010DOI: 10.1016/j.jacc.2012.10.010
Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study (Journal article)
Lip, G. Y. H., Lane, D. A., Buller, H., & Apostolakis, S. (2013). Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 144(6), 1839-1847. doi:10.1378/chest.13-1635DOI: 10.1378/chest.13-1635
Dietary self-care and negative emotions in Type 2 diabetes: 'I break it and then I feel guilty and then I don't go back' (Conference Paper)
Amankwah-Poku, M., Larkin, M., Lane, D. A., Jones, J., & Nouwen, A. (2013). Dietary self-care and negative emotions in Type 2 diabetes: 'I break it and then I feel guilty and then I don't go back'. In DIABETIC MEDICINE Vol. 30 (pp. 121). Retrieved from https://www.webofscience.com/
Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues (Chapter)
Tay, K. -H., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2013). Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues. In Handbook of Oral Anticoagulation (pp. 41-51). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_4DOI: 10.1007/978-1-908517-96-8_4
Psychological influence of the media on patients commencing oral anticoagulation in atrial fibrillation; a qualitative analysis (Conference Paper)
Xuereb, B. C., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2013). Psychological influence of the media on patients commencing oral anticoagulation in atrial fibrillation; a qualitative analysis. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 11 (pp. 827-828). Retrieved from https://www.webofscience.com/
Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke (Journal article)
Ahmad, Y., Lip, G. Y. H., & Lane, D. A. (2013). Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke. CANADIAN JOURNAL OF CARDIOLOGY, 29(7), S4-S13. doi:10.1016/j.cjca.2013.03.009DOI: 10.1016/j.cjca.2013.03.009
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study (Journal article)
Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brugemann, J., . . . Van Gelder, I. C. (2013). Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study. NETHERLANDS HEART JOURNAL, 21(7-8), 354-363. doi:10.1007/s12471-013-0428-5DOI: 10.1007/s12471-013-0428-5
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives. (Journal article)
Durrant, J., Lip, G. Y. H., & Lane, D. A. (2013). Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives.. Expert review of cardiovascular therapy, 11(1), 77-90. doi:10.1586/erc.12.161DOI: 10.1586/erc.12.161
2012
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 108(6), 1009-1022. doi:10.1160/TH12-08-0578DOI: 10.1160/TH12-08-0578
To the Editor-Adding renal dysfunction to CHA<sub>2</sub>DS<sub>2</sub>-VASc improves stroke prediction postcatheter ablation (Journal article)
Lane, D. A., & Banerjee, A. (2012). To the Editor-Adding renal dysfunction to CHA<sub>2</sub>DS<sub>2</sub>-VASc improves stroke prediction postcatheter ablation. HEART RHYTHM, 9(12), E25. doi:10.1016/j.hrthm.2012.10.022DOI: 10.1016/j.hrthm.2012.10.022
Chronic Atrial Fibrillation (Journal article)
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2012). Chronic Atrial Fibrillation. AMERICAN FAMILY PHYSICIAN, 86(8), 757-758. Retrieved from https://www.webofscience.com/
A meta-synthesis of qualitative studies exploring patients' and healthcare professionals views of atrial fibrillation and oral anticoagulant therapy (Conference Paper)
Xuereb, C. B., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2012). A meta-synthesis of qualitative studies exploring patients' and healthcare professionals views of atrial fibrillation and oral anticoagulant therapy. In THROMBOSIS RESEARCH Vol. 130 (pp. S112-S113). doi:10.1016/j.thromres.2012.08.035DOI: 10.1016/j.thromres.2012.08.035
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012). Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 5(5), 941-948. doi:10.1161/CIRCEP.112.972869DOI: 10.1161/CIRCEP.112.972869
Oral anticoagulation in atrial fibrillation, the patients and physicians experiences of the consultation: A qualitative study (Conference Paper)
Xuereb, C. B., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2012). Oral anticoagulation in atrial fibrillation, the patients and physicians experiences of the consultation: A qualitative study. In THROMBOSIS RESEARCH Vol. 130 (pp. S193). doi:10.1016/j.thromres.2012.08.241DOI: 10.1016/j.thromres.2012.08.241
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation (Journal article)
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2012). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 60(9), 861-867. doi:10.1016/j.jacc.2012.06.019DOI: 10.1016/j.jacc.2012.06.019
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease (Journal article)
Olesen, J. B., Lip, G. Y. H., Kamper, A. -L., Hommel, K., Kober, L., Lane, D. A., . . . Torp-Pedersen, C. (2012). Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 367(7), 625-635. doi:10.1056/NEJMoa1105594DOI: 10.1056/NEJMoa1105594
Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2012). Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation. CIRCULATION, 126(7), 860-865. doi:10.1161/CIRCULATIONAHA.111.060061DOI: 10.1161/CIRCULATIONAHA.111.060061
Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis (Journal article)
Xuereb, C. B., Shaw, R. L., & Lane, D. A. (2012). Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis. PATIENT EDUCATION AND COUNSELING, 88(2), 330-337. doi:10.1016/j.pec.2012.05.011DOI: 10.1016/j.pec.2012.05.011
Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Kober, L., Hansen, M. L., Karasoy, D., . . . Torp-Pedersen, C. (2012). Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 125(8). doi:10.1016/j.amjmed.2011.11.024DOI: 10.1016/j.amjmed.2011.11.024
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. EUROPEAN JOURNAL OF HEART FAILURE, 14(7), 681-695. doi:10.1093/eurjhf/hfs073DOI: 10.1093/eurjhf/hfs073
RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. (Journal article)
Stott, D. J., Dewar, R. I., Garratt, C. J., Griffith, K. E., Harding, N. J., James, M. A., . . . Trueland, J. (2012). RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.. The journal of the Royal College of Physicians of Edinburgh, 42(1), 34-35. doi:10.4997/jrcpe.2012.s01DOI: 10.4997/jrcpe.2012.s01
Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(3), 194-198. doi:10.1177/0003319711410308DOI: 10.1177/0003319711410308
RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. (Conference Paper)
Stott, D. J., Dewar, R. I., Garratt, C. J., Griffith, K. E., Harding, N. J., James, M. A., . . . Royal College of Physicians of Edinburgh. (2012). RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.. In The journal of the Royal College of Physicians of Edinburgh Vol. 42 Suppl 18 (pp. 3-4). doi:10.4997/jrcpe.2012.s01DOI: 10.4997/jrcpe.2012.s01
Development of a cardiologist delivered service leads to improved outcomes following admission with acute coronary syndromes in a large district general hospital. (Journal article)
Ng Kam Chuen, M. J., Schofield, R., Sankaranarayanan, R., Crowe, C., Helm, K., Lane, D., . . . Balachandran, K. P. (2012). Development of a cardiologist delivered service leads to improved outcomes following admission with acute coronary syndromes in a large district general hospital.. Acute cardiac care, 14(1), 1-4. doi:10.3109/17482941.2012.655290DOI: 10.3109/17482941.2012.655290
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2012). Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. EUROPEAN JOURNAL OF HEART FAILURE, 14(3), 295-301. doi:10.1093/eurjhf/hfs005DOI: 10.1093/eurjhf/hfs005
Atrial fibrillation (Conference Paper)
Lip, G. Y. H., Tse, H. F., & Lane, D. A. (2012). Atrial fibrillation. In LANCET Vol. 379 (pp. 648-661). doi:10.1016/S0140-6736(11)61514-6DOI: 10.1016/S0140-6736(11)61514-6
The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage Not Ready for Clinical Use (Journal article)
Olesen, J. B., Pisters, R., Roldans, V., Marin, F., & Lane, D. A. (2012). The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage Not Ready for Clinical Use. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 59(2), 194-195. doi:10.1016/j.jacc.2011.08.071DOI: 10.1016/j.jacc.2011.08.071
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Journal article)
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., . . . Lip, G. Y. H. (2012). Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST, 141(2), E531S-E575S. doi:10.1378/chest.11-2304DOI: 10.1378/chest.11-2304
Bleeding risk assessment and management in atrial fibrillation patients Summary of a Position Document from the European Heart Rhythm Association, endorsed by the ESC Working Group on Thrombosis. (Journal article)
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Camm, J. (2012). Bleeding risk assessment and management in atrial fibrillation patients Summary of a Position Document from the European Heart Rhythm Association, endorsed by the ESC Working Group on Thrombosis.. EUROPEAN HEART JOURNAL, 33(2), 147-149. doi:10.1093/eurheartj/ehr431DOI: 10.1093/eurheartj/ehr431
Chronic kidney disease in atrial fibrillation: risks of stroke and bleeding and the effect of antithrombotic treatment (Conference Paper)
Olesen, J. B., Lip, G. Y. H., Kamper, A. -L., Hommel, K., Kober, L., Lane, D. A., . . . Torp-Pedersen, C. (2012). Chronic kidney disease in atrial fibrillation: risks of stroke and bleeding and the effect of antithrombotic treatment. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 176). Retrieved from https://www.webofscience.com/
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference (Conference Paper)
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., . . . Camm, A. J. (2012). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 14 (pp. 8-27). doi:10.1093/europace/eur241DOI: 10.1093/europace/eur241
Increased prevalence of anxiety and depression in atrial fibrillation patients following oral anticoagulant treatment initiation (Conference Paper)
Smith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2012). Increased prevalence of anxiety and depression in atrial fibrillation patients following oral anticoagulant treatment initiation. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 57-58). Retrieved from https://www.webofscience.com/
Intensive educational intervention improves time in therapeutic range in atrial fibrillation patients initiating warfarin: results from the TREAT study (Conference Paper)
Smith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2012). Intensive educational intervention improves time in therapeutic range in atrial fibrillation patients initiating warfarin: results from the TREAT study. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 56). Retrieved from https://www.webofscience.com/
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study (Journal article)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2012). Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. JOURNAL OF HYPERTENSION, 30(5), 974-979. doi:10.1097/HJH.0b013e3283526e47DOI: 10.1097/HJH.0b013e3283526e47
Net clinical benefit of apixaban among patients with atrial fibrillation (Conference Paper)
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2012). Net clinical benefit of apixaban among patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 58). Retrieved from https://www.webofscience.com/
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study (Journal article)
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012). Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 107(3), 584-589. doi:10.1160/TH11-11-0784DOI: 10.1160/TH11-11-0784
Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Olesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2012). Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 141(1), 147-153. doi:10.1378/chest.11-0862DOI: 10.1378/chest.11-0862
Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(1), 35-38. doi:10.1177/0003319711406901DOI: 10.1177/0003319711406901
Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema - (Journal article)
Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012). Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema -. CIRCULATION JOURNAL, 76(10), 2289-2304. doi:10.1253/circj.CJ-12-1036DOI: 10.1253/circj.CJ-12-1036
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe (Journal article)
Lip, G. Y. H., Brechin, C. M., & Lane, D. A. (2012). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe. CHEST, 142(6), 1489-1498. doi:10.1378/chest.11-2888DOI: 10.1378/chest.11-2888
The Impact of Smoking on Thromboembolism and Mortality in Patients with Atrial Fibrillation: The Diet, Cancer and Health Study (Conference Paper)
Albertsen, I. E., Rasmussen, L. H., Lane, D. A., Overvad, T. F., Skjoth, F., Overvad, K., . . . Larsen, T. B. (2012). The Impact of Smoking on Thromboembolism and Mortality in Patients with Atrial Fibrillation: The Diet, Cancer and Health Study. In CIRCULATION Vol. 126. Retrieved from https://www.webofscience.com/
2011
Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Kirchhof, P. (2011). Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 106(6), 997-1011. doi:10.1160/TH11-10-0690DOI: 10.1160/TH11-10-0690
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference (Journal article)
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaeaeb, S., . . . Camm, A. J. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. THROMBOSIS AND HAEMOSTASIS, 106(6), 1012-1019. doi:10.1160/TH11-07-0517DOI: 10.1160/TH11-07-0517
The Quest for New Anticoagulants: From Clinical Development to Clinical Practice (Journal article)
Apostolakis, S., Lip, G. Y. H., Lane, D. A., & Shantsila, E. (2011). The Quest for New Anticoagulants: From Clinical Development to Clinical Practice. CARDIOVASCULAR THERAPEUTICS, 29(6), E12-E22. doi:10.1111/j.1755-5922.2010.00160.xDOI: 10.1111/j.1755-5922.2010.00160.x
Atrial fibrillation (chronic). (Journal article)
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2011). Atrial fibrillation (chronic).. BMJ clinical evidence, 2011, 0217.
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation (Journal article)
Riva, N., Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. AGE AND AGEING, 40(6), 653-655. doi:10.1093/ageing/afr128DOI: 10.1093/ageing/afr128
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study (Journal article)
Olesen, J. B., Lip, G. Y. H., Lindhardsen, J., Lane, D. A., Ahlehoff, O., Hansen, M. L., . . . Torp-Pedersen, C. (2011). Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 106(4), 739-749. doi:10.1160/TH11-05-0364DOI: 10.1160/TH11-05-0364
Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. (2011). Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(13), 1398-1399. doi:10.1016/j.jacc.2011.03.065DOI: 10.1016/j.jacc.2011.03.065
An epidemic of atrial fibrillation? (Journal article)
Olesen, J. B., Lip, G. Y. H., & Lane, D. A. (2011). An epidemic of atrial fibrillation?. EUROPACE, 13(8), 1059-1060. doi:10.1093/europace/eur141DOI: 10.1093/europace/eur141
Strategies to Improve Oral Anticoagulation Management (Journal article)
Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Strategies to Improve Oral Anticoagulation Management. CHEST, 140(2), 281-282. doi:10.1378/chest.11-0418DOI: 10.1378/chest.11-0418
Angiogenin and apoptosis in hypertension in pregnancy (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Lane, D. A., & Blann, A. D. (2011). Angiogenin and apoptosis in hypertension in pregnancy. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 1(3-4), 191-196. doi:10.1016/j.preghy.2011.07.002DOI: 10.1016/j.preghy.2011.07.002
Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study (Journal article)
Lane, D. A., Kamphuisen, P. W., Minini, P., Buller, H. R., & Lip, G. Y. H. (2011). Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 140(1), 146-155. doi:10.1378/chest.10-3270DOI: 10.1378/chest.10-3270
Bleeding risk with oral anticoagulation - new frontiers and new questions (Journal article)
Banerjee, A., Lane, D. A., & Lip, G. Y. H. (2011). Bleeding risk with oral anticoagulation - new frontiers and new questions. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(7), 719-721. doi:10.1111/j.1742-1241.2011.02716.xDOI: 10.1111/j.1742-1241.2011.02716.x
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor (Journal article)
Karthikeyan, V. J., Blann, A. D., Baghdadi, S., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2011). Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. CLINICAL RESEARCH IN CARDIOLOGY, 100(6), 531-537. doi:10.1007/s00392-010-0277-9DOI: 10.1007/s00392-010-0277-9
Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i> (Journal article)
Pisters, R., Lane, D. A., Nieuwlaat, R., Crijns, H. J. G. M., & Lip, G. Y. H. (2011). Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i>. CHEST, 139(5), 1248. doi:10.1378/chest.11-0184DOI: 10.1378/chest.11-0184
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Camm, J. (2011). Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. EUROPACE, 13(5), 723-746. doi:10.1093/europace/eur126DOI: 10.1093/europace/eur126
Patel, J. V., Gill, P. S., Chackathayil, J., Ojukwu, H., Stemman, P., Sheldon, L., . . . Hughes, E. A. (2011). Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study.. Cardiology research and practice, 2011, 493546. doi:10.4061/2011/493546DOI: 10.4061/2011/493546
Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk (Journal article)
Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011). Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(12), 1339-1348. doi:10.1016/j.jacc.2010.12.013DOI: 10.1016/j.jacc.2010.12.013
Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat" (Journal article)
Tapp, L. D., Lip, G. Y. H., & Lane, D. A. (2011). Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat". CHEST, 139(2), 240-243. doi:10.1378/chest.10-1102DOI: 10.1378/chest.10-1102
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011). Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(2), 173-180. doi:10.1016/j.jacc.2010.09.024DOI: 10.1016/j.jacc.2010.09.024
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice (Journal article)
van Staa, T. P., Setakis, E., di Tanna, G. L., Lane, D. A., & Lip, G. Y. H. (2011). A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(1), 39-48. doi:10.1111/j.1538-7836.2010.04085.xDOI: 10.1111/j.1538-7836.2010.04085.x
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies (Journal article)
Karthikeyan, V. J., Ferner, R. E., Baghdadi, S., Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2011). Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. JOURNAL OF HYPERTENSION, 29(2), 396-399. doi:10.1097/HJH.0b013e328341885dDOI: 10.1097/HJH.0b013e328341885d
Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients? (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2011). Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients?. CHEST, 139(1), 10-13. doi:10.1378/chest.10-1127DOI: 10.1378/chest.10-1127
Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? (Conference Paper)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2011). Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension?. In EUROPEAN HEART JOURNAL Vol. 32 (pp. 108). Retrieved from https://www.webofscience.com/
Does pulse pressure have an impact on outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension register (Conference Paper)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2011). Does pulse pressure have an impact on outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension register. In EUROPEAN HEART JOURNAL Vol. 32 (pp. 1073). Retrieved from https://www.webofscience.com/
Rates of thromboembolism and bleeding with antithrombotic treatment in patients with atrial fibrillation: a "real world" nationwide cohort study (Conference Paper)
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Ahlehoff, O., Lindhardsen, J., Olsen, A. M. S., . . . Torp-Pedersen, C. (2011). Rates of thromboembolism and bleeding with antithrombotic treatment in patients with atrial fibrillation: a "real world" nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 32 (pp. 465). Retrieved from https://www.webofscience.com/
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010) (Journal article)
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2011). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010). AGE AND AGEING, 40(1), 141. doi:10.1093/ageing/afq128DOI: 10.1093/ageing/afq128
Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population (Journal article)
Poli, D., Lip, G. Y., Antonucci, E., Grifoni, E., & Lane, D. (2011). Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 22(1), 25-30. doi:10.1111/j.1540-8167.2010.01858.xDOI: 10.1111/j.1540-8167.2010.01858.x
2010
Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk. LANCET NEUROLOGY, 9(12), 1140-1142. doi:10.1016/S1474-4422(10)70275-1DOI: 10.1016/S1474-4422(10)70275-1
Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010). Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort. STROKE, 41(12), 2731-2738. doi:10.1161/STROKEAHA.110.590257DOI: 10.1161/STROKEAHA.110.590257
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now? (Journal article)
Pamukcu, B., Lane, D. A., & Lip, G. Y. H. (2010). The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?. Expert review of cardiovascular therapy, 8(12), 1703-1710. doi:10.1586/erc.10.153DOI: 10.1586/erc.10.153
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey (Journal article)
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey. CHEST, 138(5), 1093-1100. doi:10.1378/chest.10-0134DOI: 10.1378/chest.10-0134
Stroke prevention in atrial fibrillation patients (Journal article)
Marinigh, R., Lip, G. Y. H., & Lane, D. A. (2010). Stroke prevention in atrial fibrillation patients. EXPERT OPINION ON PHARMACOTHERAPY, 11(14), 2331-2350. doi:10.1517/14656566.2010.498819DOI: 10.1517/14656566.2010.498819
Quality of anticoagulation control in atrial fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Quality of anticoagulation control in atrial fibrillation. LANCET, 376(9745), 935-937. doi:10.1016/S0140-6736(10)61305-0DOI: 10.1016/S0140-6736(10)61305-0
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis (Journal article)
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010). Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56(11), 827-837. doi:10.1016/j.jacc.2010.05.028DOI: 10.1016/j.jacc.2010.05.028
Atrial fibrillation and mortality: the impact of antithrombotic therapy (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Atrial fibrillation and mortality: the impact of antithrombotic therapy. EUROPEAN HEART JOURNAL, 31(17), 2075-2076. doi:10.1093/eurheartj/ehp486DOI: 10.1093/eurheartj/ehp486
Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients? (Journal article)
Lip, G. Y. H., & Lane, D. A. (2010). Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?. AMERICAN JOURNAL OF MEDICINE, 123(9), 785-789. doi:10.1016/j.amjmed.2010.01.031DOI: 10.1016/j.amjmed.2010.01.031
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (Journal article)
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2010). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores. AGE AND AGEING, 39(5), 533-535. doi:10.1093/ageing/afq059DOI: 10.1093/ageing/afq059
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients (Journal article)
Kaireviciute, D., Blann, A. D., Balakrishnan, B., Lane, D. A., Patel, J. V., Uzdavinys, G., . . . Lip, G. Y. H. (2010). Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. THROMBOSIS AND HAEMOSTASIS, 104(1), 122-127. doi:10.1160/TH09-12-0837DOI: 10.1160/TH09-12-0837
TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT) (Journal article)
Smith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2010). TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC CARDIOVASCULAR DISORDERS, 10. doi:10.1186/1471-2261-10-21DOI: 10.1186/1471-2261-10-21
Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1 (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 21(5), 508-510. doi:10.1111/j.1540-8167.2009.01687.xDOI: 10.1111/j.1540-8167.2009.01687.x
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint (Journal article)
Smith, D., Lip, G. Y. H., & Lane, D. A. (2010). Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint. EUROPACE, 12(5), 608-610. doi:10.1093/europace/euq083DOI: 10.1093/europace/euq083
Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range?. THROMBOSIS AND HAEMOSTASIS, 103(2), 254-256. doi:10.1160/TH09-12-0843DOI: 10.1160/TH09-12-0843
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation (Journal article)
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation. CHEST, 137(2), 263-272. doi:10.1378/chest.09-1584DOI: 10.1378/chest.09-1584
Risk factors for stroke in 79,884 atrial fibrillation patients in primary care in the United Kingdom (Conference Paper)
Lane, D. A., Van Staa, T. P., Setakis, E., Di Tanna, G. L., & Lip, G. Y. H. (2010). Risk factors for stroke in 79,884 atrial fibrillation patients in primary care in the United Kingdom. In EUROPEAN HEART JOURNAL Vol. 31 (pp. 154). Retrieved from https://www.webofscience.com/
Safety and efficacy of anticoagulation for secondary stroke prevention in atrial fibrillation patients: the AMADEUS trial (Conference Paper)
Lane, D. A., Kamphuisen, P. W., Minini, P., Buller, H. R., & Lip, G. Y. H. (2010). Safety and efficacy of anticoagulation for secondary stroke prevention in atrial fibrillation patients: the AMADEUS trial. In EUROPEAN HEART JOURNAL Vol. 31 (pp. 923-924). Retrieved from https://www.webofscience.com/
2009
Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves (Journal article)
Tay, K. -H., Lane, D. A., & Lip, G. Y. H. (2009). Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves. CHEST, 136(6), 1451-1452. doi:10.1378/chest.09-1187DOI: 10.1378/chest.09-1187
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction (Journal article)
Jessani, S. S., Lane, D. A., Shantsila, E., Watson, T., Millane, T. A., & Lip, G. Y. H. (2009). Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. ANNALS OF MEDICINE, 41(8), 608-618. doi:10.1080/07853890903159256DOI: 10.1080/07853890903159256
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation" (Journal article)
Apostolakis, S., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2009). Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 914-915. doi:10.1160/TH09-08-0563DOI: 10.1160/TH09-08-0563
Improving Survival of Malignant Hypertension Patients Over 40 Years (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2009). Improving Survival of Malignant Hypertension Patients Over 40 Years. AMERICAN JOURNAL OF HYPERTENSION, 22(11), 1199-1204. doi:10.1038/ajh.2009.153DOI: 10.1038/ajh.2009.153
Treatment of hypertension in peripheral arterial disease (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD003075.pub2DOI: 10.1002/14651858.CD003075.pub2
Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients (Journal article)
Lip, G. Y. H., & Lane, D. A. (2009). Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients. REVISTA ESPANOLA DE CARDIOLOGIA, 62(9), 972-975. doi:10.1016/S0300-8932(09)72094-9DOI: 10.1016/S0300-8932(09)72094-9
Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation (Journal article)
Tay, K. -H., Lip, G. Y. H., & Lane, D. A. (2009). Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. BLOOD COAGULATION & FIBRINOLYSIS, 20(5), 392-393. doi:10.1097/MBC.0b013e32832aec47DOI: 10.1097/MBC.0b013e32832aec47
Quality of life in older people with atrial fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Quality of life in older people with atrial fibrillation. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 25(1), 37-42. doi:10.1007/s10840-008-9318-yDOI: 10.1007/s10840-008-9318-y
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 101(5), 802-805. doi:10.1160/TH09-02-0106DOI: 10.1160/TH09-02-0106
Challenges facing anticoagulation among the elderly and frail (Journal article)
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2009). Challenges facing anticoagulation among the elderly and frail. AGE AND AGEING, 38(2), 140-142. doi:10.1093/ageing/afn295DOI: 10.1093/ageing/afn295
Anticoagulation variability: is it the physician, patient or hospital? (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Anticoagulation variability: is it the physician, patient or hospital?. Journal of internal medicine, 265(3), 303-306. doi:10.1111/j.1365-2796.2008.02069.xDOI: 10.1111/j.1365-2796.2008.02069.x
Atrial fibrillation and stroke risk prevention in real-life clinical practice (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Atrial fibrillation and stroke risk prevention in real-life clinical practice. THROMBOSIS AND HAEMOSTASIS, 101(3), 415-416. doi:10.1160/TH08-10-0645DOI: 10.1160/TH08-10-0645
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation (Journal article)
Lane, D. A., Langman, C. M., Lip, G. Y. H., & Nouwen, A. (2009). Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. JOURNAL OF PSYCHOSOMATIC RESEARCH, 66(3), 203-210. doi:10.1016/j.jpsychores.2008.10.007DOI: 10.1016/j.jpsychores.2008.10.007
Patients' experience of home and hospital based cardiac rehabilitation: A focus group study (Journal article)
Jones, M. I., Greenfield, S., & Jolly, K. (2009). Patients' experience of home and hospital based cardiac rehabilitation: A focus group study. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 8(1), 9-17. doi:10.1016/j.ejcnurse.2008.06.001DOI: 10.1016/j.ejcnurse.2008.06.001
Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review (Journal article)
Krishnamoorthy, S., Lip, G. Y. H., & Lane, D. A. (2009). Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review. AMERICAN JOURNAL OF MEDICINE, 122(9), 851-U83. doi:10.1016/j.amjmed.2009.02.012DOI: 10.1016/j.amjmed.2009.02.012
Comparison of Risk Stratification Schemes for Stroke in Atrial Fibrillation (Conference Paper)
van Staa, T. P., Zhang, B., Setakis, E., Lane, D., & Lip, G. Y. (2009). Comparison of Risk Stratification Schemes for Stroke in Atrial Fibrillation. In CIRCULATION Vol. 120 (pp. S521). Retrieved from https://www.webofscience.com/
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation" (Journal article)
Healey, J. S. (2009). Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 912-913. doi:10.1160/TH09-06-0369DOI: 10.1160/TH09-06-0369
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. (Journal article)
Jolly, K., Lip, G. Y. H., Taylor, R. S., Raftery, J., Mant, J., Lane, D., . . . Stevens, A. (2009). The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation.. Heart (British Cardiac Society), 95(1), 36-42. doi:10.1136/hrt.2007.127209DOI: 10.1136/hrt.2007.127209
Vascular Endothelial Growth Factor and Soluble FMS-Like Tyrosine Kinase 1 in Hypertension in Pregnancy (Conference Paper)
Karthikeyan, V. J., Jessani, S., Balakrishnan, B., Lane, D. A., Baghdadi, S., Beevers, D. G., & Lip, G. Y. H. (2009). Vascular Endothelial Growth Factor and Soluble FMS-Like Tyrosine Kinase 1 in Hypertension in Pregnancy. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 53 (pp. A458). Retrieved from https://www.webofscience.com/
2008
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin? (Journal article)
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008). Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?. THROMBOSIS AND HAEMOSTASIS, 100(6), 955-957. doi:10.1160/TH08-10-0685DOI: 10.1160/TH08-10-0685
Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link? (Journal article)
Bennett, P. C., Lane, D. A., & Lip, G. Y. H. (2008). Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link?. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 11(4), 247-249. doi:10.1080/10253890701833029DOI: 10.1080/10253890701833029
Atrial fibrillation (chronic). (Journal article)
Boos, C. J., Lane, D. A., & Lip, G. Y. H. (2008). Atrial fibrillation (chronic).. BMJ clinical evidence, 2008, 0217.
Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors (Journal article)
Lane, D. A., & Lip, G. Y. H. (2008). Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors. STROKE, 39(1), 7-9. doi:10.1161/STROKEAHA.107.496554DOI: 10.1161/STROKEAHA.107.496554
Circulating Endothelial Cells and Circulating Progenitor Cells in hypertension in pregnancy: A balance between endothelial damage and repair? (Conference Paper)
Karthikeyan, V. J., Watson, T., Lane, D. A., Baghdadi, S., Beevers, D. G., & Lip, G. Y. H. (2008). Circulating Endothelial Cells and Circulating Progenitor Cells in hypertension in pregnancy: A balance between endothelial damage and repair?. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 51 (pp. A291). Retrieved from https://www.webofscience.com/
Circulating Endothelial Cells and plasma von Willebrand factor in hypertension in pregnancy: evidence for endothelial damage/dysfunction (Conference Paper)
Karthikeyan, V. J., Jessani, S., Boos, C. J., Lane, D. A., Baghdadi, S., Beevers, D. G., & Lip, G. Y. H. (2008). Circulating Endothelial Cells and plasma von Willebrand factor in hypertension in pregnancy: evidence for endothelial damage/dysfunction. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 51 (pp. A340). Retrieved from https://www.webofscience.com/
Circulating endothelial cells and circulating progenitor cells in hypertension in pregnancy: A balance between endothelial damage and repair? (Conference Paper)
Karthikeyan, V. J., Watson, T., Lane, D. A., Baghdadi, S., Beevers, D. G., & Lip, G. Y. H. (2008). Circulating endothelial cells and circulating progenitor cells in hypertension in pregnancy: A balance between endothelial damage and repair?. In HEART Vol. 94 (pp. A116). Retrieved from https://www.webofscience.com/
2007
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project (Journal article)
Patel, J. V., Gunarathne, A., Lane, D., Lim, H. S., Tracey, I., Panja, N. C., . . . Hughes, E. A. (2007). Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project. BMC HEALTH SERVICES RESEARCH, 7. doi:10.1186/1472-6963-7-192DOI: 10.1186/1472-6963-7-192
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. THROMBOSIS RESEARCH, 120(6), 819-847. doi:10.1016/j.thromres.2007.01.004DOI: 10.1016/j.thromres.2007.01.004
Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale (Journal article)
Lane, D. A., Jajoo, J., Taylor, R. S., Lip, G. Y. H., & Jolly, K. (2007). Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale. BMC PSYCHIATRY, 7. doi:10.1186/1471-244X-7-5DOI: 10.1186/1471-244X-7-5
A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events? (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events?. CHEST, 132(4), 1337-1347. doi:10.1378/chest.06-2978DOI: 10.1378/chest.06-2978
Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent (Journal article)
Lane, D. A., & Beevers, D. G. (2007). Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent. JOURNAL OF HYPERTENSION, 25(12), 2515-2516. doi:10.1097/HJH.0b013e3282f254d9DOI: 10.1097/HJH.0b013e3282f254d9
Cardiovascular and rheological reactivity to mental and postural stress in patients with atrial fibrillation: influence of hydration status (Conference Paper)
Lane, D. A., Thrall, G., Carroll, D., & Lip, G. Y. H. (2007). Cardiovascular and rheological reactivity to mental and postural stress in patients with atrial fibrillation: influence of hydration status. In EUROPEAN HEART JOURNAL Vol. 28 (pp. 539). Retrieved from https://www.webofscience.com/
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension (Journal article)
Boos, C. J., Lane, D. A., Karpha, M., Beevers, D. G., Haynes, R., & Lip, G. Y. H. (2007). Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. CHEST, 132(5), 1540-1547. doi:10.1378/chest.07-0428DOI: 10.1378/chest.07-0428
Depression, anxiety, and quality of life in patients with atrial fibrillation (Conference Paper)
Thrall, G., Lip, G. Y. H., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 49 (pp. 16A). Retrieved from https://www.webofscience.com/
Depression, anxiety, and quality of life in patients with atrial fibrillation (Journal article)
Thrall, G., Lip, G. Y. H., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. CHEST, 132(4), 1259-1264. doi:10.1378/chest.07-0036DOI: 10.1378/chest.07-0036
Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2007). Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 100(7), 423-431. doi:10.1093/qjmed/hcm041DOI: 10.1093/qjmed/hcm041
Low-dose spironolactone in the management of resistant hypertension: a surveillance study (Journal article)
Lane, D. A., Shah, S., & Beevers, D. G. (2007). Low-dose spironolactone in the management of resistant hypertension: a surveillance study. JOURNAL OF HYPERTENSION, 25(4), 891-894. doi:10.1097/HJH.0b013e328014954dDOI: 10.1097/HJH.0b013e328014954d
Maintaining therapeutic anticoagulation - The importance of keeping "within range" (Journal article)
Lane, D. A., & Lip, G. Y. H. (2007). Maintaining therapeutic anticoagulation - The importance of keeping "within range". CHEST, 131(5), 1277-1279. doi:10.1378/chest.07-0273DOI: 10.1378/chest.07-0273
Stress Management and Cardiovascular Disease (Chapter)
Lane, D., & Carroll, D. (2007). Stress Management and Cardiovascular Disease. In Encyclopedia of Stress (pp. 631-636). Elsevier. doi:10.1016/b978-012373947-6.00362-7DOI: 10.1016/b978-012373947-6.00362-7
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence (Journal article)
Jolly, K., Taylor, R., Lip, G. Y. H., Greenfield, S., Raftery, J., Mant, J., . . . Stevens, A. (2007). The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. HEALTH TECHNOLOGY ASSESSMENT, 11(35), 1-+. doi:10.3310/hta11350DOI: 10.3310/hta11350
2006
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood (Journal article)
Boos, C. J., Lane, D. A., Kang, D., Goon, P. K. Y., Blann, A. D., & Lip, G. Y. H. (2006). Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 22(2), 125-131. doi:10.1007/s11239-006-8422-zDOI: 10.1007/s11239-006-8422-z
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation (Journal article)
Lip, G. Y. H., Lane, D., Van Walraven, C., & Hart, R. G. (2006). Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. STROKE, 37(9), 2294-2300. doi:10.1161/01.STR.0000236840.00467.84DOI: 10.1161/01.STR.0000236840.00467.84
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project (Journal article)
Lane, D. A., Ponsford, J., Shelley, A., Sirpal, A., & Lip, G. Y. H. (2006). Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 110(3), 354-358. doi:10.1016/j.ijcard.2005.07.031DOI: 10.1016/j.ijcard.2005.07.031
Quality of life in patients with atrial fibrillation: a systematic review. (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2006). Quality of life in patients with atrial fibrillation: a systematic review.. The American journal of medicine, 119(5), 448.e1-448.19. doi:10.1016/j.amjmed.2005.10.057DOI: 10.1016/j.amjmed.2005.10.057
Additive role of plasma von Willebrand factor levels to clinical risk stratification in patients with atrial fibrillation (Conference Paper)
Lip, G. Y. H., Lane, D. A., Van Walraven, C., & Hart, R. G. (2006). Additive role of plasma von Willebrand factor levels to clinical risk stratification in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 837). Retrieved from https://www.webofscience.com/
Anticoagulation control with vitamin K antagonists - How well are we doing? (Journal article)
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2006). Anticoagulation control with vitamin K antagonists - How well are we doing?. CHEST, 129(5), 1122-1124. doi:10.1378/chest.129.5.1122DOI: 10.1378/chest.129.5.1122
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema (Journal article)
Kakar, P., Lane, D., & Lip, G. Y. H. (2006). Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema. CHEST, 130(5), 1296-1299. doi:10.1378/chest.130.5.1296DOI: 10.1378/chest.130.5.1296
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses. (Journal article)
Thrall, G., Lane, D., & Lip, G. Y. H. (2006). Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.. Thrombosis research, 117(3), 351-352. doi:10.1016/j.thromres.2005.06.018DOI: 10.1016/j.thromres.2005.06.018
2005
Review: after myocardial infarction, depression and poor prognosis are associated. (Journal article)
Lane, D. D. A., & Carroll, P. D. (2005). Review: after myocardial infarction, depression and poor prognosis are associated.. Evidence-based mental health, 8(3), 67. doi:10.1136/ebmh.8.3.67DOI: 10.1136/ebmh.8.3.67
Jolly, K., Lip, G. Y., Taylor, R. S., Mant, J. W., Lane, D. A., Lee, K. W., . . . BRUM Steering Committee. (2005). Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].. BMC medical research methodology, 5, 18. doi:10.1186/1471-2288-5-18DOI: 10.1186/1471-2288-5-18
Depression, indirect clinical markers of cardiac disease (Journal article)
Lane, D., Ring, C., Lip, G. Y. H., & Carroll, D. (2005). Depression, indirect clinical markers of cardiac disease. HEART, 91(4), 531-532. doi:10.1136/hrt.2004.036392DOI: 10.1136/hrt.2004.036392
Psychological interventions for depression in heart failure. (Journal article)
Lane, D. A., Chong, A. Y., & Lip, G. Y. H. (2005). Psychological interventions for depression in heart failure.. The Cochrane database of systematic reviews, (1), CD003329. doi:10.1002/14651858.cd003329.pub2DOI: 10.1002/14651858.cd003329.pub2
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment. (Journal article)
Lane, D., & Lip, G. Y. H. (2005). Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.. Age and ageing, 34(1), 1-3. doi:10.1093/ageing/afi008DOI: 10.1093/ageing/afi008
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification (Journal article)
Lane, D. A., & Lip, G. Y. H. (2005). Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification. BLOOD COAGULATION & FIBRINOLYSIS, 16(7), 461-464. doi:10.1097/01.mbc.0000184739.35347.13DOI: 10.1097/01.mbc.0000184739.35347.13
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2005). Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project. JOURNAL OF HYPERTENSION, 23(7), 1347-1353. doi:10.1097/01.hjh.0000173516.60610.b5DOI: 10.1097/01.hjh.0000173516.60610.b5
2004
Compliance with pharmacological therapy in hypertension: can we do better, and how? (Journal article)
Thrall, G., Lip, G. Y. H., & Lane, D. (2004). Compliance with pharmacological therapy in hypertension: can we do better, and how?. Journal of human hypertension, 18(9), 595-597. doi:10.1038/sj.jhh.1001722DOI: 10.1038/sj.jhh.1001722
Is depression a risk factor for coronary heart disease? (Journal article)
Pickering, T. G., Davidson, K., & Shimbo, D. (2004). Is depression a risk factor for coronary heart disease?. Journal of the American College of Cardiology, 44(2), 472-473. doi:10.1016/j.jacc.2004.04.029DOI: 10.1016/j.jacc.2004.04.029
Is depression following acute myocardial infarction an independent risk for mortality? (Journal article)
Lane, D., Lip, G. Y. H., & Carroll, D. (2004). Is depression following acute myocardial infarction an independent risk for mortality?. AMERICAN JOURNAL OF CARDIOLOGY, 93(10), 1333-1334. doi:10.1016/j.amjcard.2004.01.001DOI: 10.1016/j.amjcard.2004.01.001
Ethnicity and tracking blood pressure in children (Journal article)
Lane, D. A., & Gill, P. (2004). Ethnicity and tracking blood pressure in children. JOURNAL OF HUMAN HYPERTENSION, 18(4), 223-228. doi:10.1038/sj.jhh.1001674DOI: 10.1038/sj.jhh.1001674
2003
Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association? (Journal article)
Lane, D., Carroll, D., & Lip, G. Y. H. (2003). Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 42(10), 1808-1810. doi:10.1016/j.jacc.2003.08.018DOI: 10.1016/j.jacc.2003.08.018
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263] (Journal article)
Jolly, K., Lip, G. Y. H., Sandercock, J., Greenfield, S. M., Raftery, J. P., Mant, J., . . . Stevens, A. J. (2003). Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]. BMC CARDIOVASCULAR DISORDERS, 3. doi:10.1186/1471-2261-3-10DOI: 10.1186/1471-2261-3-10
Ethnicity, blood pressure and all-cause mortality in the Birmingham Factory Screening Project (Conference Paper)
Lip, G. Y. H., Lane, D. A., & Beevers, D. G. (2003). Ethnicity, blood pressure and all-cause mortality in the Birmingham Factory Screening Project. In AMERICAN JOURNAL OF HYPERTENSION Vol. 16 (pp. 211A-212A). doi:10.1016/S0895-7061(03)00650-2DOI: 10.1016/S0895-7061(03)00650-2
Obesity, blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: The Birmingham Factory Screening Project (Conference Paper)
Lip, G. Y. H., Lane, D. A., & Beevers, D. G. (2003). Obesity, blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: The Birmingham Factory Screening Project. In AMERICAN JOURNAL OF HYPERTENSION Vol. 16 (pp. 212A). Retrieved from https://www.webofscience.com/
Psychological interventions for depression in adolescent and adult congenital heart disease. (Journal article)
Lip, G. Y. H., Lane, D. A., Millane, T. A., & Tayebjee, M. H. (2003). Psychological interventions for depression in adolescent and adult congenital heart disease.. The Cochrane database of systematic reviews, (3), CD004394. doi:10.1002/14651858.cd004394DOI: 10.1002/14651858.cd004394
Smoking status in relation to blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: The Birmingham Factory Screening Project (Conference Paper)
Lip, G. Y. H., Lane, D. A., & Beevers, D. G. (2003). Smoking status in relation to blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: The Birmingham Factory Screening Project. In AMERICAN JOURNAL OF HYPERTENSION Vol. 16 (pp. 212A). Retrieved from https://www.webofscience.com/
Treatment of hypertension in peripheral arterial disease. (Journal article)
Lip, G. Y. H., & Makin, A. J. (2003). Treatment of hypertension in peripheral arterial disease.. The Cochrane database of systematic reviews, (4), CD003075. doi:10.1002/14651858.cd003075DOI: 10.1002/14651858.cd003075
2002
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 31(6), 1179-1182. doi:10.1093/ije/31.6.1179DOI: 10.1093/ije/31.6.1179
Quality of life in adults with congenital heart disease (Journal article)
Lane, D. A., Lip, G. Y. H., & Millane, T. A. (2002). Quality of life in adults with congenital heart disease. HEART, 88(1), 71-75. doi:10.1136/heart.88.1.71DOI: 10.1136/heart.88.1.71
Ethnic differences in blood pressure and the prevalence of hypertension in England (Journal article)
Lane, D., Beevers, D. G., & Lip, G. Y. H. (2002). Ethnic differences in blood pressure and the prevalence of hypertension in England. JOURNAL OF HUMAN HYPERTENSION, 16(4), 267-273. doi:10.1038/sj.jhh.1001371DOI: 10.1038/sj.jhh.1001371
The prevalence and persistence of depression and anxiety following myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). The prevalence and persistence of depression and anxiety following myocardial infarction. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 7, 11-21. doi:10.1348/135910702169321DOI: 10.1348/135910702169321
Depression and mortality following myocardial infarction: the issue of disease severity. (Journal article)
Carroll, D., & Lane, D. (2002). Depression and mortality following myocardial infarction: the issue of disease severity.. Epidemiologia e psichiatria sociale, 11(2), 65-68. doi:10.1017/s1121189x00005510DOI: 10.1017/s1121189x00005510
Inter-arm differences in blood pressure: when are they clinically significant? (Journal article)
Lane, D., Beevers, M., Barnes, N., Bourne, J., John, A., Malins, S., & Beevers, D. G. (2002). Inter-arm differences in blood pressure: when are they clinically significant?. JOURNAL OF HYPERTENSION, 20(6), 1089-1095. doi:10.1097/00004872-200206000-00019DOI: 10.1097/00004872-200206000-00019
Persistence of left ventricular hypertrophy in normotensive adult survivors of coarctation repair in childhood (Conference Paper)
Chung, N. A. Y., Lane, D. A., Lip, G. Y. H., Beevers, D. G., & Millane, T. A. (2002). Persistence of left ventricular hypertrophy in normotensive adult survivors of coarctation repair in childhood. In EUROPEAN HEART JOURNAL Vol. 23 (pp. 313). Retrieved from https://www.webofscience.com/
2001
Blood pressure in different ethnic groups. (Journal article)
Lane, D., & Lip, G. Y. (2001). Blood pressure in different ethnic groups.. The American journal of cardiology, 88(10), 1218-1219. doi:10.1016/s0002-9149(01)01963-4DOI: 10.1016/s0002-9149(01)01963-4
Predictors of attendance at cardiac rehabilitation after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Predictors of attendance at cardiac rehabilitation after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 51(3), 497-501. doi:10.1016/S0022-3999(01)00225-2DOI: 10.1016/S0022-3999(01)00225-2
Ethnic differences in hypertension and blood pressure control in the UK (Journal article)
Lane, D. A., & Lip, G. Y. H. (2001). Ethnic differences in hypertension and blood pressure control in the UK. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 94(7), 391-396. doi:10.1093/qjmed/94.7.391DOI: 10.1093/qjmed/94.7.391
Cardiovascular and behavioral reactions to stress and cerebrovascular disease (Journal article)
Lane, D. A., Carroll, D., & Lip, G. Y. H. (2001). Cardiovascular and behavioral reactions to stress and cerebrovascular disease. STROKE, 32(8), 1718-1720. Retrieved from https://www.webofscience.com/
Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety. PSYCHOSOMATIC MEDICINE, 63(2), 221-230. doi:10.1097/00006842-200103000-00005DOI: 10.1097/00006842-200103000-00005
Quality-of-life in grown-up congenital heart disease (Conference Paper)
Lane, D. A., Lip, G. Y. H., & Millane, T. A. (2001). Quality-of-life in grown-up congenital heart disease. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 37 (pp. 466A). Retrieved from https://www.webofscience.com/
2000
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 49(4), 229-238. doi:10.1016/S0022-3999(00)00170-7DOI: 10.1016/S0022-3999(00)00170-7
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 93(11), 739-744. doi:10.1093/qjmed/93.11.739DOI: 10.1093/qjmed/93.11.739
1999
Psychology in coronary care (Journal article)
Lane, D., Carroll, D., & Lip, G. Y. H. (1999). Psychology in coronary care. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 92(8), 425-431. doi:10.1093/qjmed/92.8.425DOI: 10.1093/qjmed/92.8.425
